Crossroads Systems 10-K 14 Jan 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Oct. 31, 2014	Jan. 09, 2015	Apr. 30, 2014
Document Information [Line Items]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Oct-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Registrant Name	CROSSROADS SYSTEMS INC
Entity Central Index Key	1093207
Current Fiscal Year End Date	-21
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$22,877,023
Trading Symbol	CRDS
Entity Common Stock, Shares Outstanding		16,032,993

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Oct. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$4,676	$7,795
Restricted cash	270	0
Total cash, cash equivalents and restricted cash	4,946	7,795
Accounts receivable, net of allowance for doubtful accounts of $151 and $94, respectively	2,252	2,301
Inventory	357	313
Prepaid expenses and other current assets	798	694
Total current assets	8,353	11,103
Property and equipment, net	440	1,031
Other assets	63	256
Total assets	8,856	12,390
Current liabilities:
Accounts payable	1,443	1,066
Accrued expenses	1,397	2,095
Deferred revenue	1,032	1,090
Current portion of long term debt, net of debt discount	3,160	1,605
Total current liabilities	7,032	5,856
Long term debt, net of debt discount	1,651	6,984
Long term derivative liability	0	772
Other long term liabilities	423	299
Commitments and contingencies (See Note 8)
Convertible preferred stock, $0.001 par value, 25,000,000 shares authorized, 4,231,154 shares issued and outstanding, net at October 31, 2013 (transferred to stockholders equity as of April 30, 2014)(Note 9)	0	6,394
Stockholders' deficit:
Common stock, $0.001 par value, 75,000,000 shares authorized, 15,831,810 and 11,949,937 shares issued and outstanding, respectively	16	12
Convertible preferred stock, $0.001 par value, 25,000,000 shares authorized, 3,318,197 shares issued and outstanding, net	3	0
Additional paid-in capital	226,208	208,702
Accumulated other comprehensive loss	-60	-51
Accumulated deficit	-226,417	-216,578
Total stockholders' deficit	-250	-7,915
Total liabilities and stockholders' deficit	$8,856	$12,390

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)	Oct. 31, 2014	Oct. 31, 2013
In Thousands, except Share data, unless otherwise specified
Allowance for Doubtful Accounts (in dollars)	$151	$94
Convertible Preferred Stock, Temporary Equity, Par Value (in dollars per share)	$0	$0.00
Convertible Preferred Stock, Temporary Equity, Shares Authorized	0	25,000,000
Convertible Preferred Stock, Temporary Equity, Shares Issued	0	4,231,154
Convertible Preferred Stock, Temporary Equity, Shares Outstanding	0	4,231,154
Common Stock, Par Value (in dollars per share)	$0.00	$0.00
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Shares Issued	15,831,810	11,949,937
Common Stock, Shares Outstanding	15,831,810	11,949,937
Convertible Preferred Stock, Par Value (in dollars per share)	$0.00	$0
Convertible Preferred Stock, Shares Authorized	25,000,000	0
Convertible Preferred Stock, Shares Issued	3,318,197	0
Convertible Preferred Stock, Shares Outstanding	3,318,197	0

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Revenue:
Product	$4,048	$5,412
IP license, royalty and other	7,101	7,222
Total revenue	11,149	12,634
Cost of revenue:
Product	945	777
IP license, royalty and other	1,120	2,401
Total cost of revenue	2,065	3,178
Gross profit	9,084	9,456
Operating expenses:
Sales and marketing	3,668	6,941
Research and development	5,675	10,475
General and administrative	5,247	4,728
Total operating expenses	14,590	22,144
Loss from operations	-5,506	-12,688
Gain on settlement	1,050	0
Loss before other expenses	-4,456	-12,688
Other expense:
Interest expense	-815	-539
Amortization of debt discount and issuance costs	-1,231	-370
Change in value of derivative liability	-2,765	1,538
Other expense	40	2
Net loss	-9,227	-12,057
Dividends attributable to preferred stock	-484	-2,208
Net loss available to common stockholders, basic and diluted	($9,711)	($14,265)
Net loss per share available to common stockholders, basic and diluted (in dollars per share)	($0.69)	($1.20)
Weighted average number of common shares outstanding, basic and diluted (in shares)	14,164,069	11,857,879

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Net Loss	($9,227)	($12,057)
Other comprehensive income:
Foreign currenty translation adjustments	-9	-12
Comprehensive income (loss)	($9,236)	($12,069)

CONSOLIDATED_STATEMENTS_OF_CHA

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERSb DEFICIT (USD $)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
In Thousands, except Share data
Balance at Oct. 31, 2012	$1,997	$0	$12	$204,582	($202,558)	($39)
Balance (in shares) at Oct. 31, 2012		0	11,679,860
Issuance of common stock/Private Placement	9	0	0	9	0	0
Issuance of common stock/Private Placement (in shares)		0	4,928
Stock options exercised	77	0	0	77	0	0
Stock options exercised (in shares)	61,497	0	61,497
Stock-based compensation	1,357	0	0	1,357	0	0
Stock-based compensation (in shares)		0	146,555
Warrants issued with long term debt	1,374	0	0	1,374	0	0
Warrants issued with preferred stock	1,543	0		1,543
Deemed dividend on reclassification of warrants	-2,310	0	0	-1,543	-767	0
Beneficial conversion of preferred stock	0	0	0	1,090	-1,090	0
Common stock dividends issued to preferred shareholders	0	0	0	106	-106	0
Common stock dividends issued to preferred shareholders (in shares)		0	57,097
Beneficial conversion feature on convertible notes	107	0	0	107	0	0
Foreign currency translation adjustment	-12	0	0	0	0	-12
Net loss	-12,057	0	0	0	-12,057	0
Balance at Oct. 31, 2013	-7,915	0	12	208,702	-216,578	-51
Balance (in shares) at Oct. 31, 2013		0	11,949,937
Issuance of common stock/Private Placement	4,336	0	2	4,334	0	0
Issuance of common stock/Private Placement (in shares)		0	1,986,622
Transfer from temporary equity	6,394	4	0	6,390	0	0
Transfer from temporary equity (in shares)		4,231,154	0
Stock options exercised	592	0	1	591	0	0
Stock options exercised (in shares)	390,073	0	390,073
Stock-based compensation	1,435	0	0	1,435	0	0
Stock-based compensation (in shares)		0	66,081
Warrants exercised	822	0	0	822	0	0
Warrants exercised (in shares)		0	302,041
Preferred shares converted to common	0	-1	1	0	0	0
Preferred shares converted to common (in shaes)		-912,957	912,957
Ratchet expiration	3,322	0	0	3,322	0	0
Common stock dividends issued to preferred shareholders	0	0	0	612	-612	0
Common stock dividends issued to preferred shareholders (in shares)		0	224,099
Foreign currency translation adjustment	-9	0	0	0	0	-9
Net loss	-9,227	0	0	0	-9,227	0
Balance at Oct. 31, 2014	($250)	$3	$16	$226,208	($226,417)	($60)
Balance (in shares) at Oct. 31, 2014		3,318,197	15,831,810

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Cash flows from operating activities:
Net loss	($9,227)	($12,057)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	631	821
Non cash interest paid on conversion to preferred stock	0	55
Loss (gain) on change in value of derivative liability	2,765	-1,538
Amortization of debt discount	1,231	370
(Gain) loss on disposal of property and equipment	-40	6
Stock-based compensation	1,589	1,034
Provision for doubtful accounts receivable	57	-8
Changes in assets and liabilities:
Accounts receivable	-22	563
Inventory	-44	63
Prepaid expenses and other assets	-262	-608
Accounts payable	363	-171
Accrued expenses	-832	-475
Deferred revenue	97	-199
Net cash used in operating activities	-3,694	-12,144
Cash flows from investing activities:
Purchase of property and equipment	-81	-333
Proceeds from sale of property and equipment	76	0
Net cash used in investing activities	-5	-333
Cash flows from financing activities:
Proceeds from issuance of common stock, net of expenses	5,534	87
Proceeds from issuance of preferred stock, net of expenses	0	7,333
Proceeds from issuance of bridge loan	0	550
Proceeds from issuance of debt	0	9,716
Repayment of debt	-4,672	-4,315
Net cash provided by financing activities	862	13,371
Effect of foreign exchange rate on cash and cash equivalents	-12	6
Change in cash and cash equivalents	-2,849	900
Cash and cash equivalents, beginning of period	7,795	6,895
Cash, cash equivalents, and restricted cash end of period	4,946	7,795
Supplemental disclosure of cash flow information:
Cash paid for interest	830	397
Cash paid for income taxes	0	6
Supplemental disclosure of non cash financing activities:
Conversion of promissory note to preferred stock	0	605
Conversion of preferred stock to common stock	1,378	0
Reclassification of warrants to long term derivative liability	0	2,310
Beneficial conversion feature on convertible notes	0	107
Beneficial conversion associated with preferred stock	0	1,090
Common stock dividends issued to preferred shareholders	612	106
Warrants issued with long term debt	0	1,374
Warrants issued with preferred stock	0	1,543
Conversion of derivative liability to equity	$3,537	$0

ORGANIZATION_AND_BASIS_OF_PRES

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Oct. 31, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Basis of Accounting [Text Block]	1. ORGANIZATION AND BASIS OF PRESENTATION
	The accompanying consolidated financial statements include the accounts of Crossroads Systems, Inc. and its wholly-owned subsidiaries (“Crossroads” or the “Company”). Headquartered in Austin, Texas, Crossroads Systems, a Delaware corporation, is a global provider of data archive solutions. Through the innovative use of new technologies, Crossroads delivers customer-driven solutions that enable proactive data security, advanced data archiving, optimized performance and significant cost-savings.
	Principles of Consolidation and presentation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.
	The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has accumulated significant losses as it has been developing its current and next generation products. The Company believes that cash flow from operations, customer reimbursed expenses, and proceeds from the sale of common and preferred stock will be sufficient to fund the anticipated operations for fiscal 2015.  These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time.
	KIP CR P1 LP (which we refer to as the partnership (see Note 9)), of which the Company is a limited partner and of which an affiliate of Fortress is the general partner, the investment in KIP CR P1 LP is accounted for using the equity method. The current investment balance is nominal at October 31, 2014.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.
	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash on deposit and highly liquid investments with original maturities of 90 days or less at date of purchase. While the Company’s cash and cash equivalents are on deposit with high quality FDIC and Association of German Banks insured financial institutions, at times such deposits exceed insured limits. As of October 31, 2014, total uninsured deposits were $4.5 million. The Company has not experienced any losses in such accounts.
	Allowance for Doubtful Accounts
	The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company evaluates the adequacy of its allowance on a regular basis by considering factors such as historical experience, credit quality, age of the accounts receivable balances, and current economic conditions that may affect a customer’s ability to pay. The Company makes adjustments to the allowance balance if the evaluation of allowance requirements differs from the actual aggregate reserve. This evaluation is inherently subjective and estimates may be revised as more information becomes available.
	Inventory
	Inventory is stated at the lower of cost or market. Cost is determined using standard cost, which approximates the first-in, first-out method. Adjustments to reduce the carrying value of inventory to its net realizable value are made for estimated excess, obsolete or impaired balances. These adjustments are measured as the excess of the cost of the inventory over its market value based upon assumptions about future demand and charged to cost of revenue. At the point of the loss recognition, a new, lower cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration of the original cost basis or increases in the newly established cost basis.
	Property and Equipment
	Property and equipment are stated at historical cost, net of accumulated depreciation. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets (Note 4). Expenditures for repairs and maintenance are charged to expense when incurred; major replacements and betterments are capitalized at cost. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the related asset or the remaining life of the lease. Upon retirement or disposition of property and equipment, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in operations.
	Impairment of Long-lived Assets
	The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparison of its carrying amount to future undiscounted cash flows the assets are expected to generate. The Company considers historical performance and future estimated results in its evaluation of impairment.
	The Company measures the amount of impairment by comparing the carrying amount of the asset to its fair value, generally measured by discounting expected future cash flows at the rate it utilizes to evaluate potential investments. Because the Company operates as a single reporting unit, the Company is considered as a whole when evaluating long-lived assets for impairment.
	Derivative Liabilities
	The Company, in accordance with ASC 815-40-25 and ASC 815-10-15 Derivatives and Hedging and ASC 480-10-25 Liabilities-Distinguishing Liabilities from Equity, convertible preferred shares are accounted for net, outside of stockholder’s equity and warrants are accounted for as liabilities at their fair value during periods where the full ratchet anti-dilution provision is in effect.
	Revenue Recognition
	Revenue consists of sales of hardware, software and services, as well as royalties the Company earns for products and the license of certain intellectual property as detailed below. Revenue is recognized when it is realizable and earned. Revenue is considered realizable and earned when: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the price to the buyer is fixed or determinable; and when collectability is reasonably assured.
	Product Revenue
	Product revenue includes software licenses delivered via license key and software solutions delivered via a hardware appliance. Product sales include a perpetual license to the Company’s software that is essential to the functionality of the hardware. Revenue for products sold to strategic partners, including value added resellers (“VARs”) and original equipment manufacturers (“OEMs”), and to end users is generally recognized upon shipment. When significant post-delivery obligations exist, the related revenue is deferred until such obligations are fulfilled. If there are customer acceptance criteria in the contract, the Company recognizes revenue upon end user acceptance, which typically occurs after delivery and installation are completed.
	The Company licenses certain software to OEM customers under licensing agreements that allow those customers to embed this software into specific products they offer. Licensees pay a fee based on the amount of sales of their products that incorporate the licensed software. On a periodic and timely basis, the licensees provide reports listing sales to end users for which a license fee is owed to the Company. This report is cross-referenced to the license keys electronically delivered by the Company. As the license keys substantiate delivery, and the customer reports substantiate acceptance, the Company recognizes revenue based on the information in these reports.
	Shipping charges billed to customers are included in product revenue and the related shipping costs are included in cost of product revenue.
	In the period revenue is recognized, allowances are provided for future product returns. These allowances are based on programs in existence at the time revenue is recognized and historical product return rates. Since the Company has historically been able to reliably estimate the amount of returns, revenue is recognized, net of allowances for future returns, upon shipment to customers.
	Out-of-warranty repairs are included in product revenue and recognized upon completion of the repair. On occasion, installation and professional services may also be delivered with the product as part of a bundled solution. Revenue related to installation and professional services is recognized upon completion.
	IP License, Royalty and Other Revenue
	IP license, royalty and other revenue consists of revenue from the licensing of intellectual property (“IP”), royalty payments from Hewlett Packard (“HP”), and sales of post-contract support (“PCS”) service.
	IP License Revenue
	The Company licenses patented technology to customers under licensing agreements that allow those customers to utilize the technology in specific products they offer. The timing and amount of revenue recognized from IP license agreements depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements are reviewed for multiple elements. Multiple elements can include amounts related to initial non-refundable license fees for the use of the Company’s patents in the customer’s past shipments, patent licensing royalties on covered products sold going forward, cross-licensing terms between the Company and other parties, and settlement of patent litigation. Through October 31, 2014, no amounts have been allocated to the cross-licensing or the settlement of patent litigation elements.
	Revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.
	Under these IP license agreements, one or a combination of the following forms of payment is received as consideration for permitting customers to use the Company’s patents in their applications and products:
	Consideration for Past Sales:  Consideration related to a customer’s product sales from prior periods results from a negotiated agreement with a customer that utilized the Company’s patented technologies prior to signing an IP license agreement with the Company. The Company negotiates an amount with the customer based on a report provided by the customer detailing their past shipments utilizing the Company’s patented technology. The Company may use publicly filed financial statements, research reports and other sources to determine the reasonableness of this shipment report. To determine the amount of consideration owed to the Company, the amount of past shipments is then multiplied by a standard royalty rate historically received by the Company in similar arrangements. The consideration is recorded as revenue when a signed agreement has been obtained, a determinable price has been identified based on past shipments, and payment is determined to be collectable and reasonably assured.
	Recurring Royalty Payments:  These are royalty payments covering a customer’s obligations to pay royalties relating to its sales of covered products shipped in the current reporting period. The rate used for recurring royalty payments is the same as that used to determine the consideration for past shipments. Customers that owe the Company recurring royalty payments are obligated to provide quarterly royalty reports that summarize their sales of covered products and their related royalty obligations. These royalty reports are typically received subsequent to the period in which the customers’ underlying sales occurred. Upon initially signing an agreement, the Company recognizes revenue during the period in which the royalty report and payment are received. Once history has been established with a customer, the Company estimates revenue based on prior quarterly royalty reports received. When the actual results are received, the recorded revenue is adjusted to actual results, if necessary. To date, such adjustments have not been material.
	Royalty Revenue
	Royalty revenue consists of revenue from royalty payments from HP for product and PCS services. Revenue from royalty payments from HP is recognized when earned or when amounts can be reasonably estimated based on monthly product shipping reports received from HP.
	Other Revenue
	Other revenue consists of revenue from the sales of PCS services to customers other than HP. Most product sales include PCS services which consist of software updates and customer support. Software updates provide customers access to maintenance releases and patches released during the term of the support period. Support includes telephone and internet access to technical support personnel and hardware support. For PCS services, revenue equal to the separately stated price of these service contracts is initially deferred and recognized as revenue ratably over the contract period.
	Multiple Element Arrangements
	When elements such as hardware, software and PCS service are contained in a single arrangement, or in related arrangements with the same customer, the Company allocates revenue to each element in an arrangement based on relative selling price using a selling price hierarchy. The selling price for a deliverable is based on its vendor specific objective evidence (“VSOE”), if available. Third party evidence (“TPE”) is used only if VSOE is not available, and the Company’s best estimate of selling price (“ESP”) is used if neither VSOE nor TPE is available. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items.
	For established products, the Company uses VSOE. For new products, installation and professional services for which the Company is unable to establish selling price using VSOE or TPE, the Company uses ESP. The objective of ESP is to determine the price at which the Company would transact a sale if these items were sold on a standalone basis. In determining ESP, the Company uses the cost to provide the new product, installation or professional service plus a margin. When using cost plus a margin, the Company considers the total cost of the item to establish strategic partner pricing. The Company also considers the historical margins for established products and other factors, including any changes to pricing methodologies, competitiveness of new products, installation and professional services, pricing pressures due to entering a new market, and cost drivers that could cause future margins to differ from historical margins.
	The Company determines VSOE for established products and PCS service based on the price charged to customers when sold separately. PCS service revenue is recognized under a proportional performance method, ratably over the life of the contract.
	Contracts to Modify or Customize Products
	The Company periodically enters into contracts with certain customers to significantly modify or customize products. In accounting for such arrangements, the Company first looks to the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 985-605, Software - Revenue Recognition (“ASC 985-605”), and then ASC Subtopic 605-25, Revenue Recognition – Multiple-Element Arrangements, to determine the appropriate accounting elements in the arrangement. The Company then considers the appropriate recognition model for each accounting element based on the nature of the element and applies the guidance in ASC Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts, ASC Subtopic 985-60, ASC Subtopic 605-15, Revenue Recognition – Products, or ASC Subtopic 605-20, Revenue Recognition – Services, as applicable. Amounts allocated to the modification/customization service element are evaluated for classification in the consolidated statement of operations as either revenue or reduction of research and development expense based on the following considerations: whether and in what circumstances the consideration received is refundable, ownership of the final product and intellectual property rights to develop the product, and exclusivity of the final product.
	Warranty
	Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by its products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services. The Company does not believe, based on information available, that it is probable that any material amounts will be paid under these guarantees.
	The Company provides for the estimated cost to repair or replace products under warranty and technical support costs when the related product revenue is recognized. The Company warrants products for a period from 12 to 39 months following the sale of its products. A reserve for warranty costs is recorded based upon the historical level of warranty claims and management’s estimate of future costs.
	Income Taxes
	The Company accounts for income taxes in accordance with the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates that are expected to apply to taxable income in the periods in which the deferred tax asset or liability is expected to be realized or settled. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. The Company has provided a full valuation allowance against its deferred tax assets because the realization of the related tax benefits is not considered more likely than not.
	The Company recognizes the tax benefit from an uncertain tax position only if it meets the “more likely than not” threshold that the position will be sustained upon examination by the taxing authority, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. The Company includes interest and penalties related to its uncertain tax positions, if any, as part of income tax expense within its consolidated statement of operations (Note 11).
	Computation of Net Loss Per Share
	Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by giving effect to all dilutive potential common shares that were outstanding during the period. Basic earnings per share excludes the dilutive effect of common stock equivalents such as stock options and warrants, while earnings per share, assuming dilution, includes such dilutive effects. Future weighted-average shares outstanding calculations will be impacted by the following factors, among others: (i) the ongoing issuance of common stock associated with stock option and warrant exercises; (ii) any fluctuations in the Company’s stock price, which could cause changes in the number of common stock equivalents included in the earnings per share, assuming dilution computation; and (iii) the issuance of common stock to effect business combinations should the Company enter into such transactions.
	The Company has excluded all outstanding common stock equivalents from the calculation of diluted net loss per share because all such common stock equivalents are antidilutive for all periods presented. The total number of common stock equivalents excluded from the diluted net loss per common share calculation was 11,848,928 and 12,287,459 for the years ended October 31, 2014 and 2013, respectively. The dilutive common stock equivalents for the year ended October 31, 2014 include warrants to purchase 5,426,664 shares of common stock, 3,318,197 shares of preferred stock, which are excluded until converted to common shares (Note 9), and stock options to purchase 3,104,067 shares of common stock.
	Net loss available to common stockholders is calculated by deducting from net income, preferred dividends paid and accrued of $ 0.5 million.
	Advertising Costs
	The Company expenses all advertising costs as incurred. Advertising costs for the year ended October 31, 2014 were $0 and for the year ended October 31, 2013 were approximately $18,000.
	Research and Development Costs
	Expenditures relating to the development of new products are expensed as incurred. These costs include expenditures for employee compensation, materials used in the development effort, other internal costs, as well as expenditures for third party professional services. Software development costs incurred after a product has reached marketability have not been material to date.
	Stock-based Compensation
	Stock-based compensation expense is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite employee service period (generally the vesting period), net of estimated forfeitures. The Company estimates the fair value of stock-based payments using the Black-Scholes option-pricing model, which requires a number of assumptions to determine the model inputs. The estimation of stock-based awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from the Company’s current estimates, such amounts will be recorded as a cumulative adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class and historical experience. Additionally, the fair value of stock-based awards to non-employees is expensed over the period in which the related services are rendered. All stock-based awards are expected to be fulfilled with new shares of common stock.
	Foreign Currency Translation
The Company's wholly-owned subsidiary outside the United States (“U.S.”), Crossroads Europe, GmbH, has a functional currency other than the U.S. dollar. Accordingly, all balance sheet accounts of this subsidiary are translated into U.S. dollars using the current exchange rate in effect at the balance sheet date, and revenues and expenses are translated using the average exchange rate in effect during the period. The gains and losses from foreign currency translation of this subsidiary’s financial statements are recorded directly as a separate component of stockholders' equity and represent all of the balance under the caption "Accumulated other comprehensive loss."
Net income recorded by Crossroads Europe, GmbH, was approximately $0.1 million during both fiscal years 2014 and 2013. Assets of Crossroads Europe, GmbH account for approximately 7% and 3% of the consolidated net assets for fiscal years 2014 and 2013, respectively.
Recently Issued Accounting Pronouncements
On March 4, 2013, the FASB issued ASU 2013-05, Foreign Currency Matters (Topic 830) Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of consolidation guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. The Company anticipates adopting ASU 2013-05 beginning November 1, 2014. The Company does not anticipate that these changes will have a material impact on its consolidated financial statements or disclosures.
In May 2014, the FASB issued guidance codified in ASC 606, Revenue Recognition — Revenue from Contracts with Customers, which amends the guidance in former ASC 605, Revenue Recognition. The guidance requires all industries to conform to the same revenue recognition guidance, as opposed to separate industry standards. The guidance is effective for interim periods within the first annual reporting period beginning after December 15, 2016. We anticipate adopting ASC 606 beginning on November 1, 2016. The Company is currently evaluating the impact of the provisions of ASC 606.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Oct. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]		2	FAIR VALUE MEASUREMENTS
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measurements, a three-tier fair value hierarchy, which prioritizes the inputs used in the valuation methodologies, is applied as follows:
	Level 1 – Valuations based on quoted prices for identical assets and liabilities in active markets.
	Level 2 –  Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
	Level 3 – Valuations based on unobservable inputs reflecting management’s assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
	As of October 31, 2014, the fair value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximates book value due to the short maturity of these instruments. Based upon borrowing rates currently available to the Company for loans with similar terms, the carrying value of its debt obligations approximates fair value. As of October 31, 2014 and 2013, the Company held no investments.
	In accordance with ASC 815-40-25 and ASC 815-10-15 Derivatives and Hedging and ASC 480-10-25 Liabilities-Distinguishing Liabilities from Equity as approved by shareholders, the Company’s shares of 5.0% Series F Convertible Preferred Stock was accounted for net outside of stockholders’ equity at $6.4 million and the warrants issued in connection with the convertible preferred stock accounted for as liabilities at their fair value of $0.8 million as of October 31, 2013. The value of the derivative warrant liability was re-measured at each reporting period with changes in fair value recorded as change in value of derivative liability. To derive an estimate of the fair value of these warrants, the Company utilized a dynamic Black Scholes Merton formula that computes the impact of share dilution upon the exercise of the warrant shares. This process relies upon inputs such as shares outstanding, estimated stock prices, strike price and volatility assumptions to dynamically adjust the payoff of the warrants in the presence of the dilution effect. In the event the convertible preferred shares are redeemed, any redemption price in excess of the carrying amount of the convertible preferred stock would be treated as a dividend. The change in liabilities measured using significant unobservable inputs for the year ended October 31, 2014 were as follows (in thousands) (see Note 8 explaining the revaluation of Series-F Preferred Stock and Warrants):
	Level 3 Roll-forward		Derivative Liability
	Balance October 31, 2013		$	772
	Derivative liability converted to equity upon exercise			-215
	Change in fair value of derivative liability			2,765
	Derivative liability reclassified to equity upon ratchet expiration			-3,322
	Balance October 31, 2014		$	-

INVENTORY

INVENTORY	12 Months Ended
	Oct. 31, 2014
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	3	INVENTORY
	Inventory, net consists of the following (in thousands):
			October 31,		October 31,
			2014		2013
	Raw materials		$	186	$	204
	Finished goods			171		109
			$	357	$	313

PROPERTY_AND_EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Oct. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]		4	PROPERTY AND EQUIPMENT
	Property and equipment, net consist of the following (in thousands, except number of years):
				October 31,		October 31,
				2014		2013
			Life (years)
	Equipment		3-Jan	$	16,635	$	18,390
	Furniture and fixtures		5		634		789
	Leasehold improvements		5		576		576
					17,845		19,755
	Less: Accumulated depreciation				-17,405		-18,724
				$	440	$	1,031
	Depreciation expense was approximately $631,000 and $821,000 for year ended October 31, 2014 and 2013, respectively.

ACCRUED_EXPENSES_AND_DEFERRED_

ACCRUED EXPENSES AND DEFERRED REVENUE	12 Months Ended
	Oct. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	5	ACCRUED EXPENSES AND DEFERRED REVENUE
	Accrued expenses consist of the following (in thousands):
			October 31,		October 31,
			2014		2013
	Payroll related		$	846	$	1,470
	Professional services			394		359
	Warranty reserve			48		41
	Other			109		225
			$	1,397	$	2,095
	Included in payroll related accrued expenses as of October 31, 2013 was $202,000 related to bonus compensation, $135,000 of which was settled in January 2014 with 66,081 shares of common stock. Also included in payroll related accrued expenses as of October 31, 2013 was $326,000 of unpaid severance, relating to the reduction in force which occurred October 24, 2013, and $142,000 of unpaid severance, relating to the termination of the Company’s previous CEO on May 8, 2013. Included in payroll related accrued expenses as of October 31, 2014 was $451,000 related to bonus compensation, $301,000 of which will be settled in the first quarter of 2015 with common stock.
	Warranty reserve activity, included in accrued expenses, during the years ended October 31, 2014 and 2013 was as follows (in thousands):
			Balance at		Charged to				Balance at
			Beginning		Costs and		Reserve		End of
			of Period		Expenses		Usage		Period
	Year ended October 31, 2013
	Warranty reserve		$	11	$	58	$	-28	$	41
	Year ended October 31, 2014
	Warranty reserve		$	41	$	31	$	-24	$	48
	Deferred revenue, current portion, consists of the following (in thousands):
			October 31,		October 31,
			2014		2013
	Product		$	-	$	47
	Services			1,032		1,043
			$	1,032	$	1,090

CONCENTRATIONS

CONCENTRATIONS	12 Months Ended
	Oct. 31, 2014
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]		6	CONCENTRATIONS
	Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.
	The Company’s sales are primarily concentrated in the United States and are primarily derived from sales to Original Equipment Manufacturers (“OEMs”) in the computer storage and server industry. Revenue is concentrated with several major customers. The loss of a major customer, a change of suppliers or a significant technological change in the industry could adversely affect operating results. The Company performs credit evaluations of its customers and generally does not require collateral on accounts receivable balances and provides allowances for potential credit losses and product sales returns. The Company has not experienced material credit losses in any of the periods presented.
	The Company relies on a limited number of suppliers for its products. The inability of any supplier to fulfill supply requirements could materially impact future operating results.
	The percentage of sales to significant customers was as follows:
			October 31,
			2014			2013
	Customer A			36.6	%		45	%
	Customer B			9.3	%		9.2	%
	Customer C			8.4	%		13.3	%
	The percentage of accounts receivable, net from significant customers was as follows:
			October 31,
			2014			2013
	Customer A			47.6	%		55.3	%
	Customer B			0.8	%		22.3	%
	Customer C			13	%		0.3	%
	The level of sales to any customer may vary from quarter to quarter. However, the Company expects that significant customer concentrations will continue for the foreseeable future. The loss of any one of these customers, or a decrease in the level of sales to any one of these customers could have a material adverse impact on the Company’s financial condition or results of operations.

LINE_OF_CREDIT_AND_LONG_TERM_L

LINE OF CREDIT AND LONG TERM LIABILITIES	12 Months Ended
	Oct. 31, 2014
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	7	LINE OF CREDIT AND LONG TERM LIABILITIES
	Effective July 22, 2013, the Company entered into a credit agreement (the Credit Agreement) with Fortress Credit Co. LLC, an affiliate of Fortress Investment Group LLC (collectively referred to as Fortress) that provided for aggregate term loan commitments of up to $10.0 million. The Credit Agreement consisted of a Term Loan A in the principal amount of $5.0 million, maturing on July 22, 2016 and bearing no interest for the first 12 months, and a Term Loan B in the principal amount of $5.0 million, maturing on February 1, 2016 and bearing no interest for the first six months. The Company drew down the full $10.0 on Term Loan A and Term Loan B (collectively referred to as Fortress Term Loans) on July 24, 2013. The Fortress Term Loans accrue interest at 10% annually after the interest free period and interest is due monthly in arrears. The Company will begin making principal payments on Term Loan A in July 2014. The proceeds from the Fortress Term Loans were used to pay off the Company’s outstanding revolving credit and term loan with Silicon Valley Bank.
	Debt issuance costs associated with the Fortress Term Loans totaling $1.7 million were recorded as a deferred charge and are being amortized over the term of the debt using the effective interest rate method with an effective interest rate of 17.82% as opposed to the statutory rate of 10%. The effective interest rate is higher due to the use of the effective interest method to calculate the monthly expense, which includes debt discount and loan origination fee amortization. Aggregate future principal payments of long-term debt outstanding are as follows as of October 31, 2014 (in thousands):
			Fiscal Year
			2015		2016		Total
	Aggregate future principal payments of long-term debt outstanding		$	3,618	$	1,709	$	5,327
	In connection with the Credit Agreement, the Company issued warrants to Fortress to purchase 1,454,545 shares of the Company’s common stock at an exercise price of $2.0625 per share (the Fortress Warrants). See Note 8 for discussion of the Fortress Warrants.
	In addition, the Company also transferred substantially all of its patents, other than its’972 patent family, to a limited partnership KIP CR P1 LP of which the Company is a limited partner and of which an affiliate of Fortress is the general partner. The partnership now controls 117 pending or granted non-’972 patents. There was no licensing activity during fiscal year 2014 associated with these patents. The general partner cannot be removed without the consent of Fortress. The Company accounts for the investment in the partnership on a consolidated basis using the equity method of accounting.
	In conjunction with the Credit Agreement the Company agreed to certain financial covenants. The Company is required to maintain a minimum of $1.5 million of unrestricted cash at each month end and the Company is restricted from making certain cash distributions to equity security holders or from incurring additional indebtedness without prior written consent from Fortress. The Company has also agreed to certain reporting covenants and must supply monthly financial statements to Fortress within 30 days of the end of each month.
	These warrants also previously contained what is commonly known as a “full-ratchet” anti-dilution provision, which provided that if the Company issued or were deemed to have issued additional shares of common stock without consideration or for a consideration per share less than the applicable exercise price of the Fortress Warrants, which is initially $2.0625 per share, then the exercise price of the warrants will be reduced on a “full ratchet” basis, concurrently with the new issue, to the consideration per share the Company received for the new issue or deemed issue of the additional shares of common stock. In January 2014, the Company and the warrant holder agreed to amend the warrant to remove this full-ratchet anti-dilution provision.
	The principal balance due to Fortress is as follows (in thousands):
			October 31,		October 31,
			2014		2013
	Principal balance Fortress Term Loans		$	5,327	$	10,000
	Unaccreted debt discount			-516		-1,411
	Net carrying value due Fortress			4,811		8,589
	Less current portion			-3,160		-1,605
	Long term portion		$	1,651	$	6,984

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Oct. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]		8	COMMITMENTS AND CONTINGENCIES
	Leases
	The Company leases office space and equipment under long-term operating lease agreements that expire on various dates through March 31, 2020. Rental expense under these agreements was approximately $445,000 and $415,000 for the years ended October 31, 2014 and 2013, respectively. Crossroads leases its headquarters, approximately 37,800 square feet of general office, laboratory, data center and administrative space in Austin, Texas. The original lease was effective October 31, 2005 and extended in accordance with an extension agreement through February 28, 2015. On May 2, 2014, the lease was amended, extending the lease through March 31, 2020, and reducing the space leased to 16,200 square feet. The extended term of the lease represents a lease commitment of approximately $252,000 per year through the lease term.
			Operating
	Fiscal Year		Leases
	2015		$	293
	2016			259
	2017			254
	2018			252
	2019			257
	Thereafter			108
			$	1,423
	Legal Proceedings
	Intellectual Property Litigation
	The Company filed a lawsuit on September 11, 2013 against Dot Hill Systems Corp. ("Dot Hill") styled Crossroads Systems, Inc. v. Dot Hill Systems Corp., Civil Action No. 1:13-CV-800-SS alleging patent infringement of U.S. Patent No. 6,425,035and breach of the Amended Settlement and License Agreement dated June 27, 2006 between Crossroads and Dot Hill. Dot Hill has filed a motion to dismiss and Crossroads has filed its response; the Court denied Dot Hill’s motion. Dot Hill filed a partial motion for summary judgment regarding whether certain products Dot Hill sells are subject to royalties under the Amended Settlement and License Agreement. Crossroads filed its response requesting summary judgment in its favor on this issue. The Court issued a ruling granting-in-part and denying-in-part each party’s motion and the case is continuing. The Markman hearing was conducted October 6-7, 2014.
	The Company filed a lawsuit on October 7, 2013 against Oracle Corporation alleging infringement by Oracle Corporation of U.S. Patent Nos. 6,425,035, 7,051,147 and 7,934,041 (the case is styled Crossroads Systems, Inc., v. Oracle Corporation; Civil Action No. 1:13-CV-895-SS (W.D. Tex., Austin Division)). Oracle has answered the complaint and the action is pending. The Markman hearing was conducted October 6-7, 2014. Oracle is also a party to four petitions for Inter Partes Review filed at the United States Patent and Trademark Office, which collectively challenge the validity of each of the patents Crossroads asserted in the lawsuit against Oracle. Crossroads has prepared and filed responses to these petitions.
	The Company filed a lawsuit on November 26, 2013 against Huawei Technologies Co. Ltd., Huawei Enterprise USA, Inc. & Huawei Technologies USA, Inc. alleging infringement of U.S. Patent Nos. 6,425,035, 7,051,147 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Huawei Technologies Co., Ltd. et al; Civil Action No. 1:13-cv-01025-SS (W.D. Tex., Austin Division)). Huawei has answered the complaint and the action is pending. The Markman hearing was conducted October 6-7, 2014. Huawei is also a party to four petitions for Inter Partes Review filed at the United States Patent and Trademark Office, which collectively challenge the validity of each of the patents Crossroads asserted in the lawsuit against Huawei. Crossroads has prepared and filed responses to these petitions.
	The Company filed a lawsuit on February 18, 2014 against Cisco Systems, Inc. alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Cisco Systems, Inc.; Civil Action No. 1:14-cv-00148-SS (W.D. Tex., Austin Division)). Cisco has answered the complaint and the action is pending. The Markman hearing was conducted October 6-7, 2014. Cisco is also a party to three petitions for Inter Partes Review filed at the United States Patent and Trademark Office, which collectively challenge the validity of each of the patents Crossroads asserted in the lawsuit against Cisco. Crossroads has prepared and filed responses to these petitions.
	The Company filed a lawsuit on February 18, 2014 against NetApp, Inc. alleging infringement of U.S. Patent Nos. 6,425,035, 7,934,041, 7,987,311 and 7,051,147 (the case is styled Crossroads Systems, Inc. v. Net App, Inc.; Civil Action No. 1:14-cv-00149-SS (W.D. Tex., Austin Division)). NetApp has answered and the action is pending. The Markman hearing was conducted October 6-7, 2014. NetApp is also a party to five petitions for Inter Partes Review filed at the United States Patent and Trademark Office, which collectively challenge the validity of each of the patents Crossroads asserted in the lawsuit against Net App. Crossroads has prepared and filed responses to these petitions.
	The Company filed a lawsuit on February 18, 2014 against Quantum Corporation alleging infringement of U.S. Patent Nos. 6,425,035 and 7,934,041 (the case is styled Crossroads Systems, Inc. v. Quantum Corporation; Civil Action No. 1:14-cv-00150-SS (W.D. Tex., Austin Division)). Quantum has answered the complaint and the action is pending. The Markman hearing is scheduled for October 6-7, 2014. Quantum is also a party to three petitions for Inter Partes Review filed at the United States Patent and Trademark Office, which collectively challenge the validity of each of the patents Crossroads asserted in the lawsuit against Quantum. Crossroads has prepared and filed responses to these petitions.
	On April 15, 2014, Quantum Corporation filed a lawsuit against Crossroads, styled Quantum Corporation v. Crossroads Systems, Inc., Civil Action No. 3:14-CV-04293-MEJ (N.D. Cal.), alleging that Crossroads infringes U.S. Patent No. 6,766,412 by making, using and selling its StrongBox products. Crossroads filed its answer to this complaint and has denied infringement. On December 4, 2014, Quantum filed an amendment to this complaint to add an allegation that Crossroads also infringes U.S. Patent No. 5,940,849 by making, using and selling its StrongBox products. Crossroads is preparing its response to this amended complaint.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Oct. 31, 2014
Stockholders Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	9	STOCKHOLDERS’ EQUITY
	2010 Private Placement
	On October 23, 2010 the Company sold 3,125,000 shares of its common stock at $3.20 per share for gross proceeds to the Company of $ 10.0 million.  In conjunction with this private placement, the Company also issued warrants to purchase an additional 1,074,212 shares of common stock with an exercise price of $3.20 per share.   Fees in the amount of $0.8 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.3 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 63%, risk free interest rate of 1.47%, and expected term of 5 years.  The warrants were exercisable immediately upon issue, and expire October 22, 2015. As of October 31, 2014, there were 949,034 warrants outstanding.
	Iron Mountain Private Placement
	On July 31, 2012, the Company issued and sold to Iron Mountain Incorporated (“IRM”) 582,524 shares of its common stock at $5.15 per share, for an aggregate purchase price of $3 million. The Company also entered in a registration rights agreement with IRM, pursuant to which the Company agreed to prepare and file a registration statement with the Securities and Exchange Commission (“SEC”) at IRM’s request, no later than sixty days following such request, and to keep it continuously effective until the shares covered by the registration statement have been sold or become eligible for sale pursuant to SEC Rule 144 without restriction on the volume of securities that may be sold in any single transaction, assuming for this purpose that the security holders are not affiliates of the Company. The shares were registered with the SEC in fiscal year 2013.
	2013 Private Placement
	On March 22, 2013, the Company entered into a securities purchase agreement with certain accredited investors for the issuance and sale in a private placement of 4,231,154 units at a purchase price of $2.0625 per unit, valued at $8.6 million, for net proceeds of approximately $7.9 million after related expenses. Each unit consists of one share of cumulative 5.0% Series F convertible preferred stock, par value $0.001 per share and a warrant to purchase one-half of a share of common stock equal per share of convertible preferred stock purchased, at an exercise price of $2.00 per whole share, subject to certain adjustments, resulting in the issuance of warrants to purchase an additional 2,282,754 shares of common stock with an exercise price of $2.00 per share. The convertible preferred stock ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. The warrants were initially valued using the Black-Scholes pricing model at approximately $2,284,000. The relative fair value of these warrants totaling $1,543,000 was initially allocated to additional paid in capital. The Black-Scholes inputs used were: expected dividend rate of 0 %, expected volatility of 63%, risk free interest rate of 0.82 %, and expected term of 5 years. This valuation resulted in a beneficial conversion feature on the convertible preferred stock of approximately $1,090,000. This amount was recorded, upon issuance, as a deemed dividend. Fees in the amount of $0.7 million relating to the stock placement were netted against proceeds. The warrants were exercisable immediately upon issue, and expire March 22, 2018. Stock dividends valued at $106,000 were issued in fiscal year 2013, by issuing 57,097 shares of common stock. During the three months ended July 31, 2014, the Company issued 73,396 dividend common shares valued at approximately $246,000. During the three months ended January 31, 2014, the Company issued 150,703 dividend common shares valued at approximately $366,000. The next dividend is due December 31, 2014.
	The warrants related to the Series F Preferred Shares were revalued at October 31, 2013 using the Black-Scholes pricing model at approximately $772,000. The dynamic Black-Scholes inputs used were: expected dividend rate of 0%, expected volatility of 65%, risk free interest rate of 1.10%, and expected term of 4.4 years. Upon the expiration of the ratchet, the warrant liability was $0.
	The convertible preferred stock has the rights, qualifications, limitations and restrictions set forth in the Certificate of Designation (the “Certificate of Designation”) filed with the Secretary of State of the State of Delaware on March 28, 2013. The Certificate of Designation authorizes issuance of up to 4,500,000 shares of convertible preferred stock, with 3,750,000 shares designated as “Sub-Series F-1” and 750,000 shares designated as “Sub-Series F-2.” The right of holders of convertible preferred stock to convert the convertible preferred stock is subject to a 9.99% beneficial ownership limitation for holders of Sub-Series F-1 and a 4.99% beneficial ownership limitation for holders of Sub-Series F-2. Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the Original Issue Date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company. If less than 90%, but at least 20%, of such shares of Sub-Series F-1 are outstanding, such holders, voting as a single class, will be entitled to elect one director of the Company. As of the date hereof, less than 90% of the aggregate number of shares of Sub-Series F-1 are outstanding, as the remainder have been voluntarily converted into common stock at the option of the holders. Therefore, the holders of the Sub-Series F-1 shares are entitled to elect one director to the board of directors. The holders of Sub-Series F-2 will not be entitled to vote on the directors elected by the holders of Sub-Series F-1. The holders of shares of the convertible preferred stock are entitled to a liquidation preference equal to the original issuance price plus any unpaid dividends.
	The Certificate of Designation contains customary anti-dilution protection for proportional adjustments (e.g. stock splits). The Series F convertible preferred stock previously included an anti-dilution provision that would adjust the conversion price of the Series F convertible preferred stock to the issue price of any equity securities the Company issued at a price less than $2.0625 per share, subject to certain exceptions. This type of provision is commonly referred to as a “full-ratchet” anti-dilution provision. This “full-ratchet” provision is no longer in effect as it was removed from the Certificate of Designation on March 14, 2014 by the requisite approval of the holders of shares of the Company’s common stock and Series F convertible preferred stock.
	The full ratchet anti-dilution provisions in the Company’s convertible preferred stock and warrants issued in its March 2013 private placement (discussed above) were not in effect until those provisions were approved by a vote of the Company’s stockholders at its 2013 annual meeting held on June 21, 2013. Upon approval of these provisions the warrants were reclassified as a derivative liability and recorded at fair value. Also upon approval of the full ratchet anti-dilution provision the Series F convertible preferred stock were potentially convertible into more shares of common stock than currently authorized, therefore those shares were classified in temporary equity. Upon the expiration of the full ratchet anti-dilution provisions in March 2014, the Company reclassified the preferred stock and warrants to permanent stockholders' equity following the stockholders vote described in the preceding paragraph.
	In accordance with ASC 815-40-25 and ASC 815-10-15 Derivatives and Hedging and ASC 480-10-25 Liabilities-Distinguishing Liabilities from Equity as approved by shareholders, the convertible preferred shares were accounted for net outside of stockholders’ equity at $6.4 million with the warrants accounted for as liabilities at their fair value of $0.8 million as of October 31, 2013. The ratchet included with the warrants expired during the second quarter of 2014 and as a result the value of the derivative warrant liability was $0 as of October 31, 2014.
	In the event the convertible preferred shares are redeemed, any redemption price in excess of the carrying amount of the convertible preferred stock would be treated as a dividend. During the year ended October 31, 2014, there were 912,957 shares of Series F Preferred shares converted to common shares.
	The Company filed a registration statement to register these securities on Form S-1 on May 10, 2013 with the Securities and Exchange Commission (“SEC”).
	Dividends on the Series F convertible preferred stock will accrue at an annual rate of 5.0% of the original issue price and will be payable on a semi-annual basis. The convertible preferred ranks senior to the common stock and each other class or series of the Company’s capital stock, whether common, preferred or otherwise, with respect to distributions of dividends and distributions upon liquidation, dissolution or winding up of the Company. Pursuant to a registration rights agreement entered into with the purchasers of the Series F convertible preferred stock, in the event that a registration statement for the resale of the common stock underlying the convertible preferred stock and March 2013 warrants was not declared effective prior to July 26, 2013 (120 days from the closing of the March 2013 private placement), then the rate at which dividends accrued on the convertible preferred stock would be increased to an annual rate of 12.0% from that date until such time as a registration statement is declared effective, at which time the dividend rate reverts to an annual rate of 5.0%. The registration statement was not declared effective by July 26, 2013, and as a result the dividend rate on the convertible preferred stock increased to an annual rate of 12.0%, until September 19, 2013 when it was declared effective. The Company may elect to satisfy the obligation to pay semi-annual dividends in cash, by distribution of common stock or a combination thereof, in the Company’s discretion.
	On February 28, 2013, in connection with the 2013 Private Placement, the Company issued convertible promissory notes to two investors, in the aggregate principal amount of $550,000. Pursuant to the terms of the notes, both note holders had the right to convert the outstanding amounts under their notes into Series F convertible preferred stock shares at a discount of 15% to the issue price of the Series F convertible preferred stock. This resulted in a beneficial conversion feature of $107,000. Each note holder exercised this right and received 188,235 Series F convertible preferred stock shares, in the case of the note holder converting $330,000 of promissory notes and interest, and 156,863 Series F convertible preferred stock shares, in the case of note holder converting $275,000 of promissory notes and interest.
	2013 Fortress Credit Agreement
	As discussed in Note 7, on July 22, 2013 the Company issued warrants to purchase 1,454,545 shares of its common stock to Fortress at $2.0625 per share. To derive an estimate of the fair value of these warrants, the Company utilized a dynamic Black Scholes Merton formula that computes the impact of share dilution upon the exercise of the warrant shares. This process relies upon inputs such as shares outstanding, estimated stock prices, strike price and volatility assumptions to dynamically adjust the payoff of the warrants in the presence of the dilution effect. The Fortress Warrant was recorded at a fair value of $1,374,000 or $1.0625 per underlying warrant share.
	The Fortress Warrant is exercisable on or after October 22, 2013 and will expire on the seventh anniversary of the effective date of the Fortress Transactions. If the Fortress Warrant is exercisable and there is no effective Registration Statement registering, or no current prospectus available for, the resale of the shares of common stock issuable upon exercise of the Fortress Warrant, then the Fortress Warrant may also be exercised at such time by means of a “cashless exercise,” determined according to the terms of the Fortress Warrant.
	The Fortress Warrants included what is commonly referred to as “full-ratchet” anti-dilution protection, which provision would only have gone into effect if approved by the Company’s stockholders at its 2014 annual meeting of stockholders. Subject to stockholder approval, if, prior to the earlier to occur of (A) twelve months following the warrant, issuance date of July 22, 2013 and (B) the date on which the Company indicates a positive earnings per share in its public disclosure, the Company issued or was deemed to have issued additional shares of Common Stock without consideration or for a consideration per share less than the applicable exercise price, which is initially $2.0625 per share, then the exercise price of the Fortress Warrant would have been reduced, concurrently with such issue, to the consideration per share received by the Company for such issue or deemed issue of the additional shares of common stock.
	On January 23, 2014, Crossroads Systems, Inc. entered into an Amendment to the Fortress Warrants with CF DB EZ LLC, which is an affiliate of Fortress. The sole purpose of this amendment was to remove the “full-ratchet” anti-dilution provision of the warrant that Crossroads issued to Fortress.
	2014 Private Placement
	On March 31, 2014 and April 4, 2014, the Company sold 1,986,622 units at $2.2565 per unit for gross proceeds of $4.5 million. Each unit consists of one share of common stock and a warrant to purchase one-half of a share of common stock.  The warrants to purchase 993,311 shares of common stock have a weighted average exercise price of $2.45 per share.   Fees in the amount of $0.2 million relating to the stock placement were netted against proceeds.  The warrants were valued at $1.1 million using the Black-Scholes model.  The Black-Scholes inputs used were:  expected dividend rate of 0%, expected volatility of 74%, risk free interest rate of 1.64%, and expected term of 2.5 years.  The warrants were exercisable upon the six-month anniversary of issue, and expire March 31, 2019. As of October 31, 2014, there were 993,311 warrants outstanding.
	As a result of credit, common stock and preferred stock transactions, the Company has the following common stock warrants outstanding at October 31, 2014:
	Warrants Outstanding
	Warrant Transaction		Warrants		Weighted
			Outstanding		Average Exercise
					Price
	2010 Private Placement			949,034	$	3.2
	2013 Private Placement			2,029,774	$	2
	2013 Fortress Credit Agreement			1,454,545	$	2.06
	2014 Private Placement			993,311	$	2.45
	Total Warrants			5,426,664

STOCK_OPTIONS_AND_STOCK_BASED_

STOCK OPTIONS AND STOCK BASED COMPENSATION	12 Months Ended
	Oct. 31, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]		10	STOCK OPTIONS AND STOCK BASED COMPENSATION
	The Company has a stock-based compensation plan available to grant incentive stock options, non-qualified stock options and restricted stock to employees and non-employee members of the board of directors and advisors.
	The Company’s 2010 Stock Incentive Plan (the “2010 Plan”) succeeded the 1999 Stock Option/Stock Issuance Plan (the “1999 Plan. As of October 31, 2014, options to purchase 436,093 shares of common stock were outstanding under the 1999 Plan, and no further grants can be made under the 1999 Plan.
	The 2010 Plan was approved by the board of directors on May 26, 2010 and became effective on August 13, 2010, upon approval by shareholders. A maximum of 3,500,000 shares of Crossroads common stock may be awarded, plus the automatic increase as detailed below. The total number of shares that will be reserved, and that may be issued, under the 2010 Plan will automatically increase on the first trading day of each calendar year, by a number of shares equal to four percent (4%) of the total outstanding shares on the last day of the prior calendar year, subject to a maximum annual increase of 250,000.  As of October 31, 2014, options to purchase 3,807,423 shares of common stock were granted from the 2010 Plan, of which 2,667,974 were outstanding. During the years ended October 31, 2014 and 2013, common stock share grants of 66,081 and 146,555, respectively, were granted from the 2010 Plan.
	As of October 31, 2014, options to purchase an aggregate of 3,104,067 shares of common stock were outstanding under the 1999 Plan and the 2010 Plan, of which 2,031,409 were vested. Under the 2010 Plan, 200,062 shares of common stock were available for future grants as of October 31, 2014. The shares of common stock reserved for future grant are reduced by 335,369 options previously exercised under the 2010 Plan, and 296,595 shares of stock granted under the 2010 Plan. The Compensation Committee of the Board of Directors determines the exercise price, term and other conditions applicable to each stock option granted under the 2010 Plan. The exercise price of stock options is set on the grant date and may not be less than the fair market value per share of the Company’s stock on that date (at market close). The 2010 Plan options generally become exercisable over a four-year period (vesting 25% after one year, the remaining 75% vesting quarterly thereafter) and expire after ten years. During 2014, the majority of the employee incentive stock option grants vest on a schedule of 25% at the end of six months and 12.5% thereafter. Stock option exercises are fulfilled with new shares of common stock.
	The Company realized stock-based compensation expense for all awards issued under the Company’s stock plans in the following line items in the consolidated statements of operations:
			Year ended October 31,
			2014			2013
	Cost of revenue		$	36		$	26
	Sales and marketing			369			303
	Research and development			541			243
	General and administrative			643			462
	Total stock-based compensation		$	1,589		$	1,034
	During the year ended October 31, 2014, share based compensation expense of approximately $301,000 was accrued for 67% of the total estimated management bonus for the fiscal year ended October 31, 2014. Accordingly, 117,577 shares of common stock were granted in January 2015 to satisfy this liability. During the year ended October 31, 2013, share based compensation expense of approximately $147,000 was accrued for 67% of the total estimated management bonus for the fiscal year ended October 31, 2013. Accordingly, 66,081 shares of common stock were granted in January 2014 to satisfy this liability.
	The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. Expected volatility is based on historical volatility of the Company’s stock. The expected term represents an estimate of the time options are expected to remain outstanding based upon historical analysis. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve in effect at the time of grant. The variables used in the Black-Scholes calculation are listed below for the respective periods:
			Year ended October 31,
			2014			2013
	Expected dividend yield			0	%		0	%
	Expected volatility			73 - 79	%		60 - 65	%
	Risk-free interest rate			1.4 - 1.7	%		0.7 - 1.5	%
	Expected term (years)			5-Apr			5-Apr
	The following table summarizes information about stock option activity for the year ended October 31, 2014:
									Weighted Average
						Weighted			Remaining		Aggregate
			Number of			Average			Contractual Term		Intrinsic
			Shares			Exercise Price			(years)		Value ($M)
	Outstanding at October 31, 2012			2,131,244		$	3.8			6.2	$	1.4
	Granted			1,815,313		$	1.81
	Forfeited			-564,150		$	4.09
	Exercised			-61,497		$	1.33
	Outstanding at October 31, 2013			3,320,910		$	2.71			6.43	$	-
	Granted			775,889		$	1.98
	Forfeited			-602,659		$	4.52
	Exercised			-390,073		$	1.52
	Outstanding and expected to vest at October 31, 2014			3,104,067		$	2.32			7.54	$	2.4
	Exercisable at October 31, 2014			2,031,409		$	2.44			6.84	$	1.6
	The weighted average fair value per option granted during the years ended October 31, 2014 and 2013 was $1.28 and $0.96 respectively. The total intrinsic value of options (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) exercised during the years ended October 31, 2014 and 2013 was $413,000 and $36,000 respectively. During the years ended October 31, 2014 and 2013, the amount of cash received from the exercise of stock options was $591,000 and $82,000, respectively.
	The Company granted 10,000 options to non-employees during the year ended October 31, 2014 with a fair value of approximately $14,000, and granted 60,000 options during the year ended October 31, 2013, with a fair value of approximately $83,000.
	At October 31, 2014, there was approximately $0.1 million of total unrecognized compensation cost related to non-vested stock option awards which is expected to be recognized over a weighted-average period of 1.0 year. There were 1,236,776 and 647,610 options that became vested during the years ended October 31, 2014 and 2013, respectively, with the total fair value of these awards of approximately $1,565,000 and $1,001,000 respectively.
	The following table shows information about outstanding stock options at October 31, 2014:
									Options Outstanding						Options Exercisable
											Weighted
											Average		Weighted				Weighted
	Range of								Shares		Remaining		Average				Average
	Exercise Prices								Outstanding		Contractual Term		Exercise Price		Shares		Exercise Price
	$	-		-		$	1.21			448,710		8.56	$	1.12		276,210	$	1.06
	$	1.24		-		$	1.54			521,506		9.01	$	1.5		296,506	$	1.47
	$	1.54		-		$	2.04			333,395		5.71	$	1.64		317,478	$	1.63
	$	2.04		-		$	2.1			831,013		8.62	$	2.1		493,779	$	2.1
	$	2.1		-		$	2.77			316,595		9.1	$	2.58		49,868	$	2.28
	$	2.77		-		$	4.48			314,594		3.53	$	3.74		306,784	$	3.74
	$	4.48		-		$	5			310,869		5.33	$	4.75		265,106	$	4.74
	$	5		-		$	7.2			27,385		5.59	$	5.77		25,678	$	5.77
	$	-		-		$	7.2			3,104,067		7.54	$	2.32		2,031,409	$	2.44

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Oct. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	11	INCOME TAXES
	There was no recorded income tax benefit related to the losses of fiscal years 2014 or 2013 due to the uncertainty of the Company generating taxable income to utilize its net operating loss carry-forwards. The provision for income taxes due to continuing operations differs from the amount computed by applying the federal statutory rate of 35% to the loss before income taxes as follows (in thousands):
			Years Ended October 31,
			2014		2013
	Federal tax benefit at statutory rate		$	-3,229	$	-4,219
	State income tax, net of federal tax benefit			-119		-164
	Effect of foreign operations			-4		-6
	Research and experimentation credit			-19		-245
	Stock based compensation			2,532		149
	Derivative Liability			1,003		-539
	Expiration of NOL			1,169		-
	Permanent differences and other			-43		144
	Change in valuation allowance			-1,290		4,880
	Tax benefit		$	-	$	-
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred taxes at October 31, 2014 and 2013 are as follows (in thousands):
			Years Ended October 31,
			2014		2013
	Deferred Tax Assets:
	Short term:
	Inventory and other reserves		$	709	$	421
	Long term:
	Net operating losses			47,823		47,581
	Research and experimentation credits			5,198		5,209
	Basis of property and equipment			237		194
	Deferred stock compensation			561		2,758
	Other			345		-
	Long term deferred tax assets			54,164		55,742
	Total deferred tax assets			54,873		56,163
	Deferred Tax Liabilities:
	Basis of property and equipment			-		-
	Deferred tax liabilities			-		-
	Valuation allowance			-54,873		-56,163
	Net deferred tax asset		$	-	$	-
	In assessing the usefulness of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. At the end of the fiscal years ended October 31, 2014 and 2013, a full valuation allowance has been provided due to uncertainties regarding the future realization of the net deferred tax assets.
	The Company had federal net operating loss carry-forwards available to reduce future taxable income of approximately $128.7 million and $128.0 million for the fiscal years ended October 31, 2014 and 2013, respectively. The Company had federal research and experimentation credits available to reduce future tax of approximately $5.2 million and $5.2 million for the fiscal years ended October 31, 2014 and 2013, respectively. The valuation allowance increased by approximately $ 4.9 million during the fiscal years ended October 31, 2013 as a result of changes in the net operating losses and decreased by $1.3 million during the fiscal year ended October 31, 2014, primarily as a result of updates to the stock compensation deferred tax asset and changes in the net operating losses. A portion of the valuation allowance relates to tax benefits for stock option deductions included in the net operating loss carry-forward which, when realized, will be allocated directly to contributed capital to the extent the benefits exceed amounts attributable to deferred stock compensation expense. The Company also had foreign net operating loss carry-forwards available to reduce future foreign income of approximately $3.9 million and $4.0 million for fiscal years ended October 31, 2014 and 2013, respectively.
	The federal net operating loss carry-forwards and research and experimentation credit carry-forwards expire from 2018 to 2033, if not utilized prior to that time. Utilization of the federal net operating losses and tax credits may be subject to substantial annual limitation due to the “change in ownership” provisions of the Internal Revenue Code of 1986. Any annual limitation may result in the expiration of net operating losses and research and experimentation credits before utilization.
	The Company does not foresee any recognition of any unrecognized tax benefits during the next twelve months. The major jurisdictions in which the Company files income tax returns include the U.S. and Germany. The Company’s income tax returns are not currently under examination by the Internal Revenue Service or other tax authorities. As of October 31, 2014, the earliest year that the Company was subject to examination in these jurisdictions was 2010. The Company recognizes interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense, if any.

EMPLOYEE_BENEFITS

EMPLOYEE BENEFITS	12 Months Ended
	Oct. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	12	EMPLOYEE BENEFITS
	In 1996, the Company established the Crossroads Systems, Inc. 401(k) Savings Plan (the “Savings Plan”), which is a qualified plan under section 401(k) of the Internal Revenue Code. All employees who have attained 18 years of age are eligible to enroll in the Savings Plan. The Company may make matching contributions to those employees participating in the Savings Plan based upon Company productivity and profitability. Company contributions vest over a period of six years. In October 2000, the Company adopted a new 401(k) Savings Plan that meets all of the criteria set forth above in the Savings Plan. The Company made matching contributions $184,000 and $276,000 during the years ended October 31, 2014 and 2013, respectively.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Oct. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]		13	RELATED PARTY TRANSACTIONS
	Iron Mountain
	On December 19, 2013, the Company and Iron Mountain mutually agreed to end their contract involving the development of a co-branded product. The Company received $1.6 million in connection with the terminated contract in the first quarter of fiscal year 2014. The Company bifurcated the payment between amounts received for work performed on the development of the product of $550,000, and a gain from settlement of $1,050,000. The Company recorded the amounts attributable to development as services revenue, and the gain on settlement was reflected as a reduction in operating expenses. IRM also agreed that it would not transfer the shares without the Company's prior written consent until the two-year anniversary date of the settlement, and that it would vote the shares consistent with the recommendation of Crossroads’ board of directors.
	2014 Private Placement
	On March 31, 2014 and April 4, 2014, we entered into Securities Purchase Agreements with certain accredited investors for the issuance and sale in a private placement (the “2014 Private Placement”) of an aggregate of 1,986,622 units, at a purchase price of $2.2565 per unit for net aggregate proceeds of approximately $4.5 million before expenses. Each unit consisted of one share of common stock and warrants to purchase one-half of a share of common stock at an exercise price of $2.46 per whole share. The lead investor of the 2014 Private Placement was Lone Star Value LP. Lone Star Value LP is controlled by Jeffrey E. Eberwein, Crossroads’ Chairman of the Board of Directors. Lone Star Value LP acquired 1,288,352 units in the placement for approximately $2.9 million.

PREFERRED_STOCK_RIGHTS

PREFERRED STOCK RIGHTS	12 Months Ended
	Oct. 31, 2014
Preferred Stock Rights [Abstract]
Preferred Stock Rights Disclosure [Text Block]		14	PREFERRED STOCK RIGHTS
	On May 23, 2014, the Company's board of directors adopted a tax benefit preservation plan (the “Plan”). The Plan is intended to diminish the risk that the Company’s ability to use net operating loss carryforwards to reduce future federal income tax obligations may become substantially limited due to an “ownership change,” as defined in Section 382 of the Internal Revenue Code. The board of directors authorized and declared a dividend distribution of one right for each outstanding share of common stock, par value $0.001 per share, and 5.0% Series F Convertible Preferred Stock, par value $0.001 per share, of the Company to stockholders of record as of the close of business on June 4, 2014. Each right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series G Participating Preferred Stock, par value $0.001 per share, of the Company at an exercise price of $14.00 per one one-thousandth of a share of Series G Participating Preferred Stock, subject to adjustment.
	The rights will become exercisable following (i) the 10th business day (or such later date as may be determined by the board of directors) after the public announcement that an acquiring person has acquired beneficial ownership of 4.99% or more of the common stock (calculated pursuant to the plan) or (ii) the 10th business day (or such later date as may be determined by the board) after a person or group announces a tender or exchange offer that would result in ownership by a person or group of 4.99% or more of the common stock (calculated pursuant to the Plan).
	In addition, upon the occurrence of certain events, the exercise price of the rights would be adjusted and holders of the rights (other than rights owned by an acquiring person or group) would be entitled to purchase common stock at approximately half of market value. Given the potential adjustment of the exercise price of the rights, the rights could cause substantial dilution to a person or group that acquires 4.99% or more of the Company's common stock on terms not approved by the Company's board of directors.
	No rights were exercisable at October 31, 2014. There is no impact to the Company's financial results as a result of the adoption of the rights plan for the year ended October 31, 2014.

SCHEDULE_II_VALUATION_AND_QUAL

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Oct. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS
	(in thousands)
		Balance at		Charged to
		Beginning		Costs and				Balance at
		of Period		Expenses		Deductions		End of Period
	Year ended October 31, 2013
	Deducted from asset accounts:
	Allowance for doubtful accounts	$	102	$	-	$	-8	$	94
	Year ended October 31, 2014
	Deducted from asset accounts:
	Allowance for doubtful accounts	$	94	$	57	$	-	$	151

ORGANIZATION_AND_BASIS_OF_PRES1

ORGANIZATION AND BASIS OF PRESENTATION (Policies)	12 Months Ended
	Oct. 31, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation and presentation
	The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany transactions have been eliminated in consolidation.
	The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has accumulated significant losses as it has been developing its current and next generation products. The Company believes that cash flow from operations, customer reimbursed expenses, and proceeds from the sale of common and preferred stock will be sufficient to fund the anticipated operations for fiscal 2015.  These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern for a reasonable period of time.
	KIP CR P1 LP (which we refer to as the partnership (see Note 9)), of which the Company is a limited partner and of which an affiliate of Fortress is the general partner, the investment in KIP CR P1 LP is accounted for using the equity method. The current investment balance is nominal at October 31, 2014.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates, and such differences may be material to the consolidated financial statements.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	Cash and cash equivalents consist of cash on deposit and highly liquid investments with original maturities of 90 days or less at date of purchase. While the Company’s cash and cash equivalents are on deposit with high quality FDIC and Association of German Banks insured financial institutions, at times such deposits exceed insured limits. As of October 31, 2014, total uninsured deposits were $4.5 million. The Company has not experienced any losses in such accounts.
Allowance For Doubtful Accounts Receivable Policy [Policy Text Block]	Allowance for Doubtful Accounts
	The allowance for doubtful accounts is based on the Company’s assessment of the collectability of customer accounts. The Company evaluates the adequacy of its allowance on a regular basis by considering factors such as historical experience, credit quality, age of the accounts receivable balances, and current economic conditions that may affect a customer’s ability to pay. The Company makes adjustments to the allowance balance if the evaluation of allowance requirements differs from the actual aggregate reserve. This evaluation is inherently subjective and estimates may be revised as more information becomes available.
Inventory, Policy [Policy Text Block]	Inventory
	Inventory is stated at the lower of cost or market. Cost is determined using standard cost, which approximates the first-in, first-out method. Adjustments to reduce the carrying value of inventory to its net realizable value are made for estimated excess, obsolete or impaired balances. These adjustments are measured as the excess of the cost of the inventory over its market value based upon assumptions about future demand and charged to cost of revenue. At the point of the loss recognition, a new, lower cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration of the original cost basis or increases in the newly established cost basis.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment
	Property and equipment are stated at historical cost, net of accumulated depreciation. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets (Note 4). Expenditures for repairs and maintenance are charged to expense when incurred; major replacements and betterments are capitalized at cost. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the related asset or the remaining life of the lease. Upon retirement or disposition of property and equipment, the cost and related accumulated depreciation are removed from the accounts and any resulting gain or loss is reflected in operations.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-lived Assets
	The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparison of its carrying amount to future undiscounted cash flows the assets are expected to generate. The Company considers historical performance and future estimated results in its evaluation of impairment.
	The Company measures the amount of impairment by comparing the carrying amount of the asset to its fair value, generally measured by discounting expected future cash flows at the rate it utilizes to evaluate potential investments. Because the Company operates as a single reporting unit, the Company is considered as a whole when evaluating long-lived assets for impairment.
Derivatives, Reporting of Derivative Activity [Policy Text Block]	Derivative Liabilities
	The Company, in accordance with ASC 815-40-25 and ASC 815-10-15 Derivatives and Hedging and ASC 480-10-25 Liabilities-Distinguishing Liabilities from Equity, convertible preferred shares are accounted for net, outside of stockholder’s equity and warrants are accounted for as liabilities at their fair value during periods where the full ratchet anti-dilution provision is in effect.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition
	Revenue consists of sales of hardware, software and services, as well as royalties the Company earns for products and the license of certain intellectual property as detailed below. Revenue is recognized when it is realizable and earned. Revenue is considered realizable and earned when: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; the price to the buyer is fixed or determinable; and when collectability is reasonably assured.
	Product Revenue
	Product revenue includes software licenses delivered via license key and software solutions delivered via a hardware appliance. Product sales include a perpetual license to the Company’s software that is essential to the functionality of the hardware. Revenue for products sold to strategic partners, including value added resellers (“VARs”) and original equipment manufacturers (“OEMs”), and to end users is generally recognized upon shipment. When significant post-delivery obligations exist, the related revenue is deferred until such obligations are fulfilled. If there are customer acceptance criteria in the contract, the Company recognizes revenue upon end user acceptance, which typically occurs after delivery and installation are completed.
	The Company licenses certain software to OEM customers under licensing agreements that allow those customers to embed this software into specific products they offer. Licensees pay a fee based on the amount of sales of their products that incorporate the licensed software. On a periodic and timely basis, the licensees provide reports listing sales to end users for which a license fee is owed to the Company. This report is cross-referenced to the license keys electronically delivered by the Company. As the license keys substantiate delivery, and the customer reports substantiate acceptance, the Company recognizes revenue based on the information in these reports.
	Shipping charges billed to customers are included in product revenue and the related shipping costs are included in cost of product revenue.
	In the period revenue is recognized, allowances are provided for future product returns. These allowances are based on programs in existence at the time revenue is recognized and historical product return rates. Since the Company has historically been able to reliably estimate the amount of returns, revenue is recognized, net of allowances for future returns, upon shipment to customers.
	Out-of-warranty repairs are included in product revenue and recognized upon completion of the repair. On occasion, installation and professional services may also be delivered with the product as part of a bundled solution. Revenue related to installation and professional services is recognized upon completion.
	IP License, Royalty and Other Revenue
	IP license, royalty and other revenue consists of revenue from the licensing of intellectual property (“IP”), royalty payments from Hewlett Packard (“HP”), and sales of post-contract support (“PCS”) service.
	IP License Revenue
	The Company licenses patented technology to customers under licensing agreements that allow those customers to utilize the technology in specific products they offer. The timing and amount of revenue recognized from IP license agreements depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements are reviewed for multiple elements. Multiple elements can include amounts related to initial non-refundable license fees for the use of the Company’s patents in the customer’s past shipments, patent licensing royalties on covered products sold going forward, cross-licensing terms between the Company and other parties, and settlement of patent litigation. Through October 31, 2014, no amounts have been allocated to the cross-licensing or the settlement of patent litigation elements.
	Revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.
	Under these IP license agreements, one or a combination of the following forms of payment is received as consideration for permitting customers to use the Company’s patents in their applications and products:
	Consideration for Past Sales:  Consideration related to a customer’s product sales from prior periods results from a negotiated agreement with a customer that utilized the Company’s patented technologies prior to signing an IP license agreement with the Company. The Company negotiates an amount with the customer based on a report provided by the customer detailing their past shipments utilizing the Company’s patented technology. The Company may use publicly filed financial statements, research reports and other sources to determine the reasonableness of this shipment report. To determine the amount of consideration owed to the Company, the amount of past shipments is then multiplied by a standard royalty rate historically received by the Company in similar arrangements. The consideration is recorded as revenue when a signed agreement has been obtained, a determinable price has been identified based on past shipments, and payment is determined to be collectable and reasonably assured.
	Recurring Royalty Payments:  These are royalty payments covering a customer’s obligations to pay royalties relating to its sales of covered products shipped in the current reporting period. The rate used for recurring royalty payments is the same as that used to determine the consideration for past shipments. Customers that owe the Company recurring royalty payments are obligated to provide quarterly royalty reports that summarize their sales of covered products and their related royalty obligations. These royalty reports are typically received subsequent to the period in which the customers’ underlying sales occurred. Upon initially signing an agreement, the Company recognizes revenue during the period in which the royalty report and payment are received. Once history has been established with a customer, the Company estimates revenue based on prior quarterly royalty reports received. When the actual results are received, the recorded revenue is adjusted to actual results, if necessary. To date, such adjustments have not been material.
	Royalty Revenue
	Royalty revenue consists of revenue from royalty payments from HP for product and PCS services. Revenue from royalty payments from HP is recognized when earned or when amounts can be reasonably estimated based on monthly product shipping reports received from HP.
	Other Revenue
	Other revenue consists of revenue from the sales of PCS services to customers other than HP. Most product sales include PCS services which consist of software updates and customer support. Software updates provide customers access to maintenance releases and patches released during the term of the support period. Support includes telephone and internet access to technical support personnel and hardware support. For PCS services, revenue equal to the separately stated price of these service contracts is initially deferred and recognized as revenue ratably over the contract period.
	Multiple Element Arrangements
	When elements such as hardware, software and PCS service are contained in a single arrangement, or in related arrangements with the same customer, the Company allocates revenue to each element in an arrangement based on relative selling price using a selling price hierarchy. The selling price for a deliverable is based on its vendor specific objective evidence (“VSOE”), if available. Third party evidence (“TPE”) is used only if VSOE is not available, and the Company’s best estimate of selling price (“ESP”) is used if neither VSOE nor TPE is available. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items.
	For established products, the Company uses VSOE. For new products, installation and professional services for which the Company is unable to establish selling price using VSOE or TPE, the Company uses ESP. The objective of ESP is to determine the price at which the Company would transact a sale if these items were sold on a standalone basis. In determining ESP, the Company uses the cost to provide the new product, installation or professional service plus a margin. When using cost plus a margin, the Company considers the total cost of the item to establish strategic partner pricing. The Company also considers the historical margins for established products and other factors, including any changes to pricing methodologies, competitiveness of new products, installation and professional services, pricing pressures due to entering a new market, and cost drivers that could cause future margins to differ from historical margins.
	The Company determines VSOE for established products and PCS service based on the price charged to customers when sold separately. PCS service revenue is recognized under a proportional performance method, ratably over the life of the contract.
Contracts To Modify Or Customize Products Policy [Policy Text Block]	Contracts to Modify or Customize Products
	The Company periodically enters into contracts with certain customers to significantly modify or customize products. In accounting for such arrangements, the Company first looks to the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 985-605, Software - Revenue Recognition (“ASC 985-605”), and then ASC Subtopic 605-25, Revenue Recognition – Multiple-Element Arrangements, to determine the appropriate accounting elements in the arrangement. The Company then considers the appropriate recognition model for each accounting element based on the nature of the element and applies the guidance in ASC Subtopic 605-35, Revenue Recognition – Construction-Type and Production-Type Contracts, ASC Subtopic 985-60, ASC Subtopic 605-15, Revenue Recognition – Products, or ASC Subtopic 605-20, Revenue Recognition – Services, as applicable. Amounts allocated to the modification/customization service element are evaluated for classification in the consolidated statement of operations as either revenue or reduction of research and development expense based on the following considerations: whether and in what circumstances the consideration received is refundable, ownership of the final product and intellectual property rights to develop the product, and exclusivity of the final product.
Standard Product Warranty, Policy [Policy Text Block]	Warranty
	Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by its products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services. The Company does not believe, based on information available, that it is probable that any material amounts will be paid under these guarantees.
	The Company provides for the estimated cost to repair or replace products under warranty and technical support costs when the related product revenue is recognized. The Company warrants products for a period from 12 to 39 months following the sale of its products. A reserve for warranty costs is recorded based upon the historical level of warranty claims and management’s estimate of future costs.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company accounts for income taxes in accordance with the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates that are expected to apply to taxable income in the periods in which the deferred tax asset or liability is expected to be realized or settled. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. The Company has provided a full valuation allowance against its deferred tax assets because the realization of the related tax benefits is not considered more likely than not.
	The Company recognizes the tax benefit from an uncertain tax position only if it meets the “more likely than not” threshold that the position will be sustained upon examination by the taxing authority, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. The Company includes interest and penalties related to its uncertain tax positions, if any, as part of income tax expense within its consolidated statement of operations (Note 11).
Earnings Per Share, Policy [Policy Text Block]	Computation of Net Loss Per Share
	Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is computed by giving effect to all dilutive potential common shares that were outstanding during the period. Basic earnings per share excludes the dilutive effect of common stock equivalents such as stock options and warrants, while earnings per share, assuming dilution, includes such dilutive effects. Future weighted-average shares outstanding calculations will be impacted by the following factors, among others: (i) the ongoing issuance of common stock associated with stock option and warrant exercises; (ii) any fluctuations in the Company’s stock price, which could cause changes in the number of common stock equivalents included in the earnings per share, assuming dilution computation; and (iii) the issuance of common stock to effect business combinations should the Company enter into such transactions.
	The Company has excluded all outstanding common stock equivalents from the calculation of diluted net loss per share because all such common stock equivalents are antidilutive for all periods presented. The total number of common stock equivalents excluded from the diluted net loss per common share calculation was 11,848,928 and 12,287,459 for the years ended October 31, 2014 and 2013, respectively. The dilutive common stock equivalents for the year ended October 31, 2014 include warrants to purchase 5,426,664 shares of common stock, 3,318,197 shares of preferred stock, which are excluded until converted to common shares (Note 9), and stock options to purchase 3,104,067 shares of common stock.
	Net loss available to common stockholders is calculated by deducting from net income, preferred dividends paid and accrued of $ 0.5 million.
Advertising Costs, Policy [Policy Text Block]	Advertising Costs
	The Company expenses all advertising costs as incurred. Advertising costs for the year ended October 31, 2014 were $0 and for the year ended October 31, 2013 were approximately $18,000.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Costs
	Expenditures relating to the development of new products are expensed as incurred. These costs include expenditures for employee compensation, materials used in the development effort, other internal costs, as well as expenditures for third party professional services. Software development costs incurred after a product has reached marketability have not been material to date.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-based Compensation
	Stock-based compensation expense is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite employee service period (generally the vesting period), net of estimated forfeitures. The Company estimates the fair value of stock-based payments using the Black-Scholes option-pricing model, which requires a number of assumptions to determine the model inputs. The estimation of stock-based awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from the Company’s current estimates, such amounts will be recorded as a cumulative adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class and historical experience. Additionally, the fair value of stock-based awards to non-employees is expensed over the period in which the related services are rendered. All stock-based awards are expected to be fulfilled with new shares of common stock.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation
	The Company's wholly-owned subsidiary outside the United States (“U.S.”), Crossroads Europe, GmbH, has a functional currency other than the U.S. dollar. Accordingly, all balance sheet accounts of this subsidiary are translated into U.S. dollars using the current exchange rate in effect at the balance sheet date, and revenues and expenses are translated using the average exchange rate in effect during the period. The gains and losses from foreign currency translation of this subsidiary’s financial statements are recorded directly as a separate component of stockholders' equity and represent all of the balance under the caption "Accumulated other comprehensive loss."
	Net income recorded by Crossroads Europe, GmbH, was approximately $0.1 million during both fiscal years 2014 and 2013. Assets of Crossroads Europe, GmbH account for approximately 7% and 3% of the consolidated net assets for fiscal years 2014 and 2013, respectively.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements
	On March 4, 2013, the FASB issued ASU 2013-05, Foreign Currency Matters (Topic 830) Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity (“ASU 2013-05”). ASU 2013-05 updates accounting guidance related to the application of consolidation guidance and foreign currency matters. This guidance resolves the diversity in practice about what guidance applies to the release of the cumulative translation adjustment into net income. This guidance is effective for interim and annual periods beginning after December 15, 2013. The Company anticipates adopting ASU 2013-05 beginning November 1, 2014. The Company does not anticipate that these changes will have a material impact on its consolidated financial statements or disclosures.
	In May 2014, the FASB issued guidance codified in ASC 606, Revenue Recognition — Revenue from Contracts with Customers, which amends the guidance in former ASC 605, Revenue Recognition. The guidance requires all industries to conform to the same revenue recognition guidance, as opposed to separate industry standards. The guidance is effective for interim periods within the first annual reporting period beginning after December 15, 2016. We anticipate adopting ASC 606 beginning on November 1, 2016. The Company is currently evaluating the impact of the provisions of ASC 606.

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Oct. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	The change in liabilities measured using significant unobservable inputs for the year ended October 31, 2014 were as follows (in thousands) (see Note 8 explaining the revaluation of Series-F Preferred Stock and Warrants):
	Level 3 Roll-forward	Derivative Liability
	Balance October 31, 2013	$	772
	Derivative liability converted to equity upon exercise		-215
	Change in fair value of derivative liability		2,765
	Derivative liability reclassified to equity upon ratchet expiration		-3,322
	Balance October 31, 2014	$	-

INVENTORY_Tables

INVENTORY (Tables)	12 Months Ended
	Oct. 31, 2014
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory, net consists of the following (in thousands):
		October 31,		October 31,
		2014		2013
	Raw materials	$	186	$	204
	Finished goods		171		109
		$	357	$	313

PROPERTY_AND_EQUIPMENT_Tables

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Oct. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property and equipment, net consist of the following (in thousands, except number of years):
			October 31,		October 31,
			2014		2013
		Life (years)
	Equipment	3-Jan	$	16,635	$	18,390
	Furniture and fixtures	5		634		789
	Leasehold improvements	5		576		576
				17,845		19,755
	Less: Accumulated depreciation			-17,405		-18,724
			$	440	$	1,031

ACCRUED_EXPENSES_AND_DEFERRED_1

ACCRUED EXPENSES AND DEFERRED REVENUE (Tables)	12 Months Ended
	Oct. 31, 2014
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	Accrued expenses consist of the following (in thousands):
		October 31,		October 31,
		2014		2013
	Payroll related	$	846	$	1,470
	Professional services		394		359
	Warranty reserve		48		41
	Other		109		225
		$	1,397	$	2,095
Schedule of Product Warranty Liability [Table Text Block]	Warranty reserve activity, included in accrued expenses, during the years ended October 31, 2014 and 2013 was as follows (in thousands):
		Balance at		Charged to				Balance at
		Beginning		Costs and		Reserve		End of
		of Period		Expenses		Usage		Period
	Year ended October 31, 2013
	Warranty reserve	$	11	$	58	$	-28	$	41
	Year ended October 31, 2014
	Warranty reserve	$	41	$	31	$	-24	$	48
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	Deferred revenue, current portion, consists of the following (in thousands):
		October 31,		October 31,
		2014		2013
	Product	$	-	$	47
	Services		1,032		1,043
		$	1,032	$	1,090

CONCENTRATIONS_Tables

CONCENTRATIONS (Tables)	12 Months Ended
	Oct. 31, 2014
Sales Revenue, Goods, Net [Member]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	The percentage of sales to significant customers was as follows:
		October 31,
		2014			2013
	Customer A		36.6	%		45	%
	Customer B		9.3	%		9.2	%
	Customer C		8.4	%		13.3	%
Accounts Receivable [Member]
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	The percentage of accounts receivable, net from significant customers was as follows:
		October 31,
		2014			2013
	Customer A		47.6	%		55.3	%
	Customer B		0.8	%		22.3	%
	Customer C		13	%		0.3	%

LINE_OF_CREDIT_AND_LONG_TERM_L1

LINE OF CREDIT AND LONG TERM LIABILITIES (Tables)	12 Months Ended
	Oct. 31, 2014
Debt Disclosure [Abstract]
Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]	Aggregate future principal payments of long-term debt outstanding are as follows as of October 31, 2014 (in thousands):
		Fiscal Year
		2015		2016		Total
	Aggregate future principal payments of long-term debt outstanding	$	3,618	$	1,709	$	5,327
Schedule of Long-term Debt Instruments [Table Text Block]	The principal balance due to Fortress is as follows (in thousands):
		October 31,		October 31,
		2014		2013
	Principal balance Fortress Term Loans	$	5,327	$	10,000
	Unaccreted debt discount		-516		-1,411
	Net carrying value due Fortress		4,811		8,589
	Less current portion		-3,160		-1,605
	Long term portion	$	1,651	$	6,984

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Oct. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]		Operating
	Fiscal Year	Leases
	2015	$	293
	2016		259
	2017		254
	2018		252
	2019		257
	Thereafter		108
		$	1,423

STOCKHOLDERS_EQUITY_Tables

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Oct. 31, 2014
Stockholders Equity Note [Abstract]
Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block]	As a result of credit, common stock and preferred stock transactions, the Company has the following common stock warrants outstanding at October 31, 2014:
	Warrants Outstanding
	Warrant Transaction	Warrants		Weighted
		Outstanding		Average Exercise
				Price
	2010 Private Placement		949,034	$	3.2
	2013 Private Placement		2,029,774	$	2
	2013 Fortress Credit Agreement		1,454,545	$	2.06
	2014 Private Placement		993,311	$	2.45
	Total Warrants		5,426,664

STOCK_OPTIONS_AND_STOCK_BASED_1

STOCK OPTIONS AND STOCK BASED COMPENSATION (Tables)	12 Months Ended
	Oct. 31, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	The Company realized stock-based compensation expense for all awards issued under the Company’s stock plans in the following line items in the consolidated statements of operations:
			Year ended October 31,
			2014			2013
	Cost of revenue		$	36		$	26
	Sales and marketing			369			303
	Research and development			541			243
	General and administrative			643			462
	Total stock-based compensation		$	1,589		$	1,034
Variables Used In Black Sholes Calculation [Table Text Block]	The variables used in the Black-Scholes calculation are listed below for the respective periods:
			Year ended October 31,
			2014			2013
	Expected dividend yield			0	%		0	%
	Expected volatility			73 - 79	%		60 - 65	%
	Risk-free interest rate			1.4 - 1.7	%		0.7 - 1.5	%
	Expected term (years)			5-Apr			5-Apr
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following table summarizes information about stock option activity for the year ended October 31, 2014:
									Weighted Average
						Weighted			Remaining		Aggregate
			Number of			Average			Contractual Term		Intrinsic
			Shares			Exercise Price			(years)		Value ($M)
	Outstanding at October 31, 2012			2,131,244		$	3.8			6.2	$	1.4
	Granted			1,815,313		$	1.81
	Forfeited			-564,150		$	4.09
	Exercised			-61,497		$	1.33
	Outstanding at October 31, 2013			3,320,910		$	2.71			6.43	$	-
	Granted			775,889		$	1.98
	Forfeited			-602,659		$	4.52
	Exercised			-390,073		$	1.52
	Outstanding and expected to vest at October 31, 2014			3,104,067		$	2.32			7.54	$	2.4
	Exercisable at October 31, 2014			2,031,409		$	2.44			6.84	$	1.6
Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans To Employees and Non Employees By Exercise Price Range [Table Text Block]	The following table shows information about outstanding stock options at October 31, 2014:
									Options Outstanding						Options Exercisable
											Weighted
											Average		Weighted				Weighted
	Range of								Shares		Remaining		Average				Average
	Exercise Prices								Outstanding		Contractual Term		Exercise Price		Shares		Exercise Price
	$	-		-		$	1.21			448,710		8.56	$	1.12		276,210	$	1.06
	$	1.24		-		$	1.54			521,506		9.01	$	1.5		296,506	$	1.47
	$	1.54		-		$	2.04			333,395		5.71	$	1.64		317,478	$	1.63
	$	2.04		-		$	2.1			831,013		8.62	$	2.1		493,779	$	2.1
	$	2.1		-		$	2.77			316,595		9.1	$	2.58		49,868	$	2.28
	$	2.77		-		$	4.48			314,594		3.53	$	3.74		306,784	$	3.74
	$	4.48		-		$	5			310,869		5.33	$	4.75		265,106	$	4.74
	$	5		-		$	7.2			27,385		5.59	$	5.77		25,678	$	5.77
	$	-		-		$	7.2			3,104,067		7.54	$	2.32		2,031,409	$	2.44

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Oct. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The provision for income taxes due to continuing operations differs from the amount computed by applying the federal statutory rate of 35% to the loss before income taxes as follows (in thousands):
		Years Ended October 31,
		2014		2013
	Federal tax benefit at statutory rate	$	-3,229	$	-4,219
	State income tax, net of federal tax benefit		-119		-164
	Effect of foreign operations		-4		-6
	Research and experimentation credit		-19		-245
	Stock based compensation		2,532		149
	Derivative Liability		1,003		-539
	Expiration of NOL		1,169		-
	Permanent differences and other		-43		144
	Change in valuation allowance		-1,290		4,880
	Tax benefit	$	-	$	-
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Significant components of the Company’s deferred taxes at October 31, 2014 and 2013 are as follows (in thousands):
		Years Ended October 31,
		2014		2013
	Deferred Tax Assets:
	Short term:
	Inventory and other reserves	$	709	$	421
	Long term:
	Net operating losses		47,823		47,581
	Research and experimentation credits		5,198		5,209
	Basis of property and equipment		237		194
	Deferred stock compensation		561		2,758
	Other		345		-
	Long term deferred tax assets		54,164		55,742
	Total deferred tax assets		54,873		56,163
	Deferred Tax Liabilities:
	Basis of property and equipment		-		-
	Deferred tax liabilities		-		-
	Valuation allowance		-54,873		-56,163
	Net deferred tax asset	$	-	$	-

ORGANIZATION_AND_BASIS_OF_PRES2

ORGANIZATION AND BASIS OF PRESENTATION (Details Textual) (USD $)	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	11,848,928	12,287,459
Preferred Stock Dividends, Paid and Accrued	$484,000	$2,208,000
Cash, Uninsured Amount	4,500,000
Advertising Expense	0	18,000
Net Income (Loss)	-9,227,000	-12,057,000
Crossroads Europe Gmbh [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net Income (Loss)	$100,000	$100,000
Percentage Of Total Assets	7.00%	3.00%
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	5,426,664
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	3,318,197
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	3,104,067

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance October 31, 2013	$772
Derivative liability converted to equity upon exercise	-215
Change in fair value of derivative liability	2,765
Derivative liability reclassified to equity upon ratchet expiration	-3,322
Balance October 31, 2014	$0

FAIR_VALUE_MEASUREMENTS_Detail1

FAIR VALUE MEASUREMENTS (Details Textual) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Value, Outstanding	6.4
Financial and Nonfinancial Liabilities, Fair Value Disclosure, Total	0.8
Series F Convertible Preferred Stock [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Dividend Rate, Percentage	5.00%

INVENTORY_Details

INVENTORY (Details) (USD $)	Oct. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Inventory [Line Items]
Raw materials	$186	$204
Finished goods	171	109
Inventory, Net	$357	$313

PROPERTY_AND_EQUIPMENT_Details

PROPERTY AND EQUIPMENT (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Property, Plant and Equipment [Line Items]
Equipment	16,635	$18,390
Furniture and fixtures	634	789
Leasehold improvements	576	576
Property, Plant and Equipment, Gross	17,845	19,755
Less: Accumulated depreciation	-17,405	-18,724
Property Plant And Equipment Net	440	$1,031
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	1 year
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years

PROPERTY_AND_EQUIPMENT_Details1

PROPERTY AND EQUIPMENT (Details Textual) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Property, Plant and Equipment [Line Items]
Depreciation	$631	$821

ACCRUED_EXPENSES_AND_DEFERRED_2

ACCRUED EXPENSES AND DEFERRED REVENUE (Details) (USD $)	Oct. 31, 2014	Oct. 31, 2013	Oct. 31, 2012
In Thousands, unless otherwise specified
Deferred Revenue Arrangement [Line Items]
Payroll related	$846	$1,470
Professional services	394	359
Warranty reserve	48	41	11
Other	109	225
Accrued Liabilities Current	$1,397	$2,095

ACCRUED_EXPENSES_AND_DEFERRED_3

ACCRUED EXPENSES AND DEFERRED REVENUE (Details 1) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Warranty reserve activity, included in accrued expenses:
Balance at Beginning of Period, Warranty reserve	$41	$11
Charged to Costs and Expenses, Warranty reserve	31	58
Reserve Usage, Warranty reserve	-24	-28
Balance at End of Period, Warranty reserve	$48	$41

ACCRUED_EXPENSES_AND_DEFERRED_4

ACCRUED EXPENSES AND DEFERRED REVENUE (Details 2) (USD $)	Oct. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Deferred Revenue Arrangement [Line Items]
Deferred revenue	$1,032	$1,090
Product [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue	0	47
Services [Member]
Deferred Revenue Arrangement [Line Items]
Deferred revenue	$1,032	$1,043

ACCRUED_EXPENSES_AND_DEFERRED_5

ACCRUED EXPENSES AND DEFERRED REVENUE (Details Textual) (USD $)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2015	Oct. 31, 2014	Oct. 31, 2013
Deferred Revenue Arrangement [Line Items]
Accrued Bonuses, Current			$451,000	$202,000
Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures	135,000
Stock Issued During Period, Shares, Share-Based Compensation, Net Of Forfeitures (in shares)	66,081
Subsequent Event [Member]
Deferred Revenue Arrangement [Line Items]
Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures		301,000
Employee Severance [Member]
Deferred Revenue Arrangement [Line Items]
Severance Costs Payable				326,000
Chief Executive Officer [Member] | Employee Severance [Member]
Deferred Revenue Arrangement [Line Items]
Severance Costs Payable				$142,000

CONCENTRATIONS_Details

CONCENTRATIONS (Details) (Sales Revenue, Goods, Net [Member])	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Customer A [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	36.60%	45.00%
Customer B [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	9.30%	9.20%
Customer C [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	8.40%	13.30%

CONCENTRATIONS_Details_1

CONCENTRATIONS (Details 1) (Accounts Receivable [Member])	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Customer A [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	47.60%	55.30%
Customer B [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	0.80%	22.30%
Customer C [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	13.00%	0.30%

LINE_OF_CREDIT_AND_LONG_TERM_L2

LINE OF CREDIT AND LONG TERM LIABILITIES (Details) (USD $)	Oct. 31, 2014
In Thousands, unless otherwise specified
2015	$3,618
2016	1,709
Total	$5,327

LINE_OF_CREDIT_AND_LONG_TERM_L3

LINE OF CREDIT AND LONG TERM LIABILITIES (Details1) (USD $)	Oct. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Line of Credit Facility [Line Items]
Net carrying value due Fortress	$5,327
Less current portion	-3,160	-1,605
Long term portion	1,651	6,984
Fortress [Member]
Line of Credit Facility [Line Items]
Principal balance Fortress Term Loans	5,327	10,000
Unaccreted debt discount	-516	-1,411
Net carrying value due Fortress	4,811	8,589
Less current portion	-3,160	-1,605
Long term portion	$1,651	$6,984

LINE_OF_CREDIT_AND_LONG_TERM_L4

LINE OF CREDIT AND LONG TERM LIABILITIES (Details Textual) (USD $)	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Jul. 24, 2013
Line of Credit Facility [Line Items]
Class of Warrant or Right, Outstanding	5,426,664
Fortress [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Face Amount		$10,000,000
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Debt Instrument Drew Down Amount			10,000,000
Debt Instrument, Description	The Company is required to maintain a minimum of $1.5 million of unrestricted cash at each month end and the Company is restricted from making certain cash distributions to equity security holders or from incurring additional indebtedness without prior written consent from Fortress. The Company has also agreed to certain reporting covenants and must supply monthly financial statements to Fortress within 30 days of the end of each month.
Debt Instrument, Interest Rate, Effective Percentage	17.82%
Debt Issuance Cost	1,700,000
Class of Warrant or Right, Outstanding	1,454,545
Class of Warrant or Right, Exercise Price of Warrants or Rights	$2.06
Term Loan A [Member] | Fortress [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Face Amount		5,000,000
Debt Instrument, Maturity Date		22-Jul-16
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Debt Instrument, Interest Rate Terms		bearing no interest for the first 12 months
Term Loan B [Member] | Fortress [Member]
Line of Credit Facility [Line Items]
Debt Instrument, Face Amount		$5,000,000
Debt Instrument, Maturity Date		1-Feb-16
Debt Instrument, Interest Rate Terms		bearing no interest for the first six months

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Details) (USD $)	Oct. 31, 2014
In Thousands, unless otherwise specified
2015	$293
2016	259
2017	254
2018	252
2019	257
Thereafter	108
Operating Leases, Future Minimum Payments Due	$1,423

COMMITMENTS_AND_CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Textual) (USD $)	0 Months Ended	12 Months Ended
	2-May-14	Oct. 31, 2014	Oct. 31, 2013
	sqft
Commitments And Contingencies [Line Items]
Operating Leases, Rent Expense, Net		$445,000	$415,000
Area of Land	16,200
Lease Commitment Value	$252,000
Crossroads Headquarters [Member]
Commitments And Contingencies [Line Items]
Area of Land		37,800

STOCKHOLDERS_EQUITY_Details

STOCKHOLDERS' EQUITY (Details) (USD $)	Oct. 31, 2014	Oct. 31, 2013
Class of Warrant or Right [Line Items]
Warrants Outstanding	5,426,664
2010 Private Placement Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding	949,034
Weighted Average Exercise Price	$3.20
2013 Private Placement Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding	2,029,774
Weighted Average Exercise Price	$2
2013 Fortress Credit Agreement Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding	1,454,545	1,454,545
Weighted Average Exercise Price	$2.06
2014 Private Placement Warrant [Member]
Class of Warrant or Right [Line Items]
Warrants Outstanding	993,311
Weighted Average Exercise Price	$2.45

STOCKHOLDERS_EQUITY_Details_Te

STOCKHOLDERS' EQUITY (Details Textual) (USD $)	12 Months Ended		0 Months Ended	3 Months Ended		12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013	Mar. 22, 2013	Jul. 31, 2014	Jan. 31, 2014	Oct. 31, 2010	Jul. 31, 2012
Class of Stock [Line Items]
Stock Issued During Period Value New Issues One	$4,336,000	$9,000
Common Stock, Shares, Issued (in shares)	15,831,810	11,949,937
Common Stock, Par Or Stated Value Per Share (in dollars per share)	$0.00	$0.00
Preferred Stock, Shares Authorized	25,000,000	0
Convertible preferred shares	0	605,000
Preferred Stock, Value, Outstanding		6,400,000
Derivative Liability, Noncurrent	0	772,000
Common Stock, Value, Issued (in shares)	16,000	12,000
Class of Warrant or Right, Outstanding	5,426,664
Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period Shares New Issues One	1,986,622	4,928
Stock Issued During Period Value New Issues One	2,000	0
Stock Issued During Period, Shares, Conversion of Convertible Securities	912,957
2013 Private Placement Warrant [Member]
Class of Stock [Line Items]
Fair Value Of Warrants		772,000	2,284,000
Fair Value Assumptions, Expected Dividend Rate		0.00%	0.00%
Fair Value Assumptions, Expected Volatility Rate		65.00%	63.00%
Fair Value Assumptions, Risk Free Interest Rate		1.10%	0.82%
Fair Value Assumptions, Expected Term		4 years 4 months 24 days	5 years
Warrants Convertible Beneficial Conversion Feature			1,090,000
Common Stock Dividends, Shares			57,097	73,396	150,703
Preferred Stock, Value, Outstanding		6,400,000
Preferred Stock, Dividend Rate, Increased Percentage		12.00%
Stock Issued During Period, Value, Stock Dividend				246,000	366,000
Fair Value of Warrant Liability		0	1,543,000
Derivative Liability, Noncurrent	0
Dividends, Stock		106,000
Class of Warrant or Right, Outstanding	2,029,774
2013 Private Placement Warrant [Member] | Common Stock [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities		912,957
2010 Private Placement Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period Shares New Issues One						3,125,000
Stock Issued During Period Value New Issues One						10,000,000
Number Of Common Stock, Shares Granted By Issue Of Warrants Under Private Placement						1,074,212
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants						$3.20
Payments of Stock Issuance Costs						800,000
Fair Value Of Warrants						1,300,000
Fair Value Assumptions, Expected Dividend Rate						0.00%
Fair Value Assumptions, Expected Volatility Rate						63.00%
Fair Value Assumptions, Risk Free Interest Rate						1.47%
Fair Value Assumptions, Expected Term						5 years
Warrants and Rights Outstanding	949,034
Investment Warrants Expiration Date						22-Oct-15
Class of Warrant or Right, Outstanding	949,034
2013 Fortress Credit Agreement Warrant [Member]
Class of Stock [Line Items]
Fair Value Of Warrants		1,374,000
Fair Value Of Warrants, Per Share		$1.06
Class of Warrant or Right, Outstanding	1,454,545	1,454,545
2014 Private Placement Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period Shares New Issues One	1,986,622
Shares Issued, Price Per Share	$2.26
Number Of Common Stock, Shares Granted By Issue Of Warrants Under Private Placement	993,311
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants	$2.45
Payments of Stock Issuance Costs	200,000
Fair Value Of Warrants	1,100,000
Fair Value Assumptions, Expected Dividend Rate	0.00%
Fair Value Assumptions, Expected Volatility Rate	74.00%
Fair Value Assumptions, Risk Free Interest Rate	1.64%
Fair Value Assumptions, Expected Term	2 years 6 months
Investment Warrants Expiration Date	31-Mar-19
Class of Warrant or Right, Outstanding	993,311
Stock Issued During Period, Value, New Issues, Gross	4,500,000
Certificate Of Designation [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized		4,500,000
Preferred Stock, Conversion Basis		The right of holders of convertible preferred stock to convert the convertible preferred stock is subject to a 9.99% beneficial ownership limitation for holders of Sub-Series F-1 and a 4.99% beneficial ownership limitation for holders of Sub-Series F-2.
Certificate Of Designation [Member] | Series F1 Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized		3,750,000
Preferred Stock, Voting Rights		Such beneficial ownership limitations may be increased or decreased by a holder of Sub-Series F-1 to any percentage not in excess of 19.99% after providing notice of such increase or decrease to the Company. For as long as at least 90% of the aggregate number of shares of Sub-Series F-1 issued on the Original Issue Date are outstanding, the holders of such Sub-Series F-1, voting as a single class, will be entitled to elect two directors of the Company.
Certificate Of Designation [Member] | Series F2 Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized		750,000
Preferred Stock, Voting Rights		The holders of Sub-Series F-2 will not be entitled to vote on the directors elected by the holders of Sub-Series F-1.
Iron Mountain Incorporated [Member]
Class of Stock [Line Items]
Common Stock, Shares, Issued (in shares)							582,524
Common Stock, Par Or Stated Value Per Share (in dollars per share)							$5.15
Common Stock, Value, Issued (in shares)							3,000,000
Investors [Member]
Class of Stock [Line Items]
Securities Purchase Agreement, Units Issuance Cost			700,000
Investors [Member] | 2013 Private Placement Warrant [Member]
Class of Stock [Line Items]
Securities Purchase Agreement, Number Of Units Issuable			4,231,154
Securities Purchase Agreement, Price Per Unit Of Units Issuable			2.0625
Securities Purchase Agreement, Value Of Units Issuable			8,600,000
Securities Purchase Agreement, Proceeds From Issuance Of Units			7,900,000
Securities Purchase Agreement, Number Of Warrants Issued			2,282,754
Units Par Or Stated Value Per Share			$0.00
Units Description			Each unit consists of one share of cumulative 5.0% Series F convertible preferred stock
Investors [Member] | Convertible Notes Payable [Member]
Class of Stock [Line Items]
Debt Instrument, Face Amount		550,000
Debt Instrument, Convertible, Terms of Conversion Feature		Pursuant to the terms of the notes, both note holders had the right to convert the outstanding amounts under their notes into Series F convertible preferred stock shares at a discount of 15% to the issue price of the Series F convertible preferred stock.
Debt Instrument, Convertible, Beneficial Conversion Feature		107,000
Investor One [Member]
Class of Stock [Line Items]
Securities Purchase Agreement, Exercise Price Of Warrants Issued		$2
Investor One [Member] | Series F Convertible Preferred Stock [Member] | Convertible Notes Payable [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		188,235
Convertible preferred shares		330,000
Investor Two [Member] | Series F Convertible Preferred Stock [Member] | Convertible Notes Payable [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Shares Issued		156,863
Convertible preferred shares		275,000
Fortress [Member]
Class of Stock [Line Items]
Debt Instrument, Face Amount	$5,327,000	$10,000,000
Class of Warrant or Right, Outstanding		1,454,545

STOCK_OPTIONS_AND_STOCK_BASED_2

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share Based Compensation To Employees and Non Employees	$1,589	$1,034
Cost of revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share Based Compensation To Employees and Non Employees	36	26
Sales and marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share Based Compensation To Employees and Non Employees	369	303
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share Based Compensation To Employees and Non Employees	541	243
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share Based Compensation To Employees and Non Employees	$643	$462

STOCK_OPTIONS_AND_STOCK_BASED_3

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 1)	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0.00%	0.00%
Expected volatility, Minimum	73.00%	60.00%
Expected volatility, Maximum	79.00%	65.00%
Risk-free interest rate, Minimum	1.40%	0.70%
Risk-free interest rate, Maximum	1.70%	1.50%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	4 years	4 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	5 years	5 years

STOCK_OPTIONS_AND_STOCK_BASED_4

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 2) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013	Oct. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Outstanding at Beginning of the period	3,320,910	2,131,244
Number of Shares, Granted	775,889	1,815,313
Number of Shares, Forfeited	-602,659	-564,150
Number of Shares, Exercised	-390,073	-61,497
Number of Shares, Outstanding and expected to vest at End of the period	3,104,067	3,320,910	2,131,244
Number of Shares, Exercisable at October 31, 2014	2,031,409
Weighted Average Exercise Price, Outstanding at Beginning of the period (in dollars per share)	$2.71	$3.80
Weighted Average Exercise Price, Granted (in dollars per share)	$1.98	$1.81
Weighted Average Exercise Price, Forfeited (in dollars per share)	$4.52	$4.09
Weighted Average Exercise Price, Exercised (in dollars per share)	$1.52	$1.33
Weighted Average Exercise Price, Outstanding and expected to vest at End of the period (in dollars per share)	$2.32	$2.71	$3.80
Weighted Average Exercise Price, Exercisable at October 31, 2014 (in dollars per share)	$2.44
Stock Options To Employees and Non Employees Outstanding and expected to vest Weighted Average Remaining Contractual Term (in years)	7 years 6 months 14 days	6 years 5 months 5 days	6 years 2 months 12 days
Weighted Average Remaining Contractual Term, Exercisable (in years)	6 years 10 months 2 days
Aggregate Intrinsic Value, Outstanding at Year End	$2.40	$0	$1.40
Average Intrinsic Value, Exercisable at October 31, 2014	$1.60

STOCK_OPTIONS_AND_STOCK_BASED_5

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details 3) (USD $)	12 Months Ended
	Oct. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$0
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$7.20
Stock Options To Employees and Non Employees Outstanding Number (in shares)	3,104,067
Weighted Average Remaining Contractual Term, Outstanding (in years)	7 years 6 months 14 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$2.32
Share Based Payment Award Options Exercisable Number (in shares)	2,031,409
Weighted Average Exercise Price, Exercisable (in dollars per share)	$2.44
Range Of Exercise Prices One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$0
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$1.21
Stock Options To Employees and Non Employees Outstanding Number (in shares)	448,710
Weighted Average Remaining Contractual Term, Outstanding (in years)	8 years 6 months 22 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$1.12
Share Based Payment Award Options Exercisable Number (in shares)	276,210
Weighted Average Exercise Price, Exercisable (in dollars per share)	$1.06
Range Of Exercise Prices Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$1.24
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$1.54
Stock Options To Employees and Non Employees Outstanding Number (in shares)	521,506
Weighted Average Remaining Contractual Term, Outstanding (in years)	9 years 4 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$1.50
Share Based Payment Award Options Exercisable Number (in shares)	296,506
Weighted Average Exercise Price, Exercisable (in dollars per share)	$1.47
Range Of Exercise Prices Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$1.54
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$2.04
Stock Options To Employees and Non Employees Outstanding Number (in shares)	333,395
Weighted Average Remaining Contractual Term, Outstanding (in years)	5 years 8 months 16 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$1.64
Share Based Payment Award Options Exercisable Number (in shares)	317,478
Weighted Average Exercise Price, Exercisable (in dollars per share)	$1.63
Range Of Exercise Prices Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$2.04
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$2.10
Stock Options To Employees and Non Employees Outstanding Number (in shares)	831,013
Weighted Average Remaining Contractual Term, Outstanding (in years)	8 years 7 months 13 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$2.10
Share Based Payment Award Options Exercisable Number (in shares)	493,779
Weighted Average Exercise Price, Exercisable (in dollars per share)	$2.10
Range Of Exercise Prices Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$2.10
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$2.77
Stock Options To Employees and Non Employees Outstanding Number (in shares)	316,595
Weighted Average Remaining Contractual Term, Outstanding (in years)	9 years 1 month 6 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$2.58
Share Based Payment Award Options Exercisable Number (in shares)	49,868
Weighted Average Exercise Price, Exercisable (in dollars per share)	$2.28
Range Of Exercise Prices Six [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$2.77
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$4.48
Stock Options To Employees and Non Employees Outstanding Number (in shares)	314,594
Weighted Average Remaining Contractual Term, Outstanding (in years)	3 years 6 months 11 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$3.74
Share Based Payment Award Options Exercisable Number (in shares)	306,784
Weighted Average Exercise Price, Exercisable (in dollars per share)	$3.74
Range Of Exercise Prices Seven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$4.48
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$5
Stock Options To Employees and Non Employees Outstanding Number (in shares)	310,869
Weighted Average Remaining Contractual Term, Outstanding (in years)	5 years 3 months 29 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$4.75
Share Based Payment Award Options Exercisable Number (in shares)	265,106
Weighted Average Exercise Price, Exercisable (in dollars per share)	$4.74
Range Of Exercise Prices Eight [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Option Plans To Employees and Non Employees Exercise Price Range Lower Range Limit (in dollars per share)	$5
Stock Option Plans To Employees and Non Employees Exercise Price Range Upper Range Limit (in dollars per share)	$7.20
Stock Options To Employees and Non Employees Outstanding Number (in shares)	27,385
Weighted Average Remaining Contractual Term, Outstanding (in years)	5 years 7 months 2 days
Stock Options To Employees and Non Employees Outstanding Weighted Average Exercise Price (in dollars per share)	$5.77
Share Based Payment Award Options Exercisable Number (in shares)	25,678
Weighted Average Exercise Price, Exercisable (in dollars per share)	$5.77

STOCK_OPTIONS_AND_STOCK_BASED_6

STOCK OPTIONS AND STOCK BASED COMPENSATION (Details Textual) (USD $)	3 Months Ended	12 Months Ended		3 Months Ended
	Jan. 31, 2014	Oct. 31, 2014	Oct. 31, 2013	Jan. 31, 2015	Oct. 31, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options To Employees and Non Employees Outstanding Number (in shares)		3,104,067	3,320,910		2,131,244
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)		$1.28	$0.96
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value		$413,000	$36,000
Proceeds from Stock Options Exercised		591,000	82,000
Expected Weighted Average Period Of Recognition Of Compensation Cost Related To Stock Options To Employees and Non Employees		1 year
Stock Options Vested By Shares To Employees and Non Employees During Period		1,236,776	647,610
Stock Options Vested To Value Of Employees and Non Employees During Period		1,565,000	1,001,000
Number of Shares, Granted		775,889	1,815,313
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		100,000
Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures	135,000
Allocated Share-based Compensation Expense		1,589,000	1,034,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		390,073	61,497
Non Employees [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Shares, Granted		10,000	60,000
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value		14,000	83,000
Subsequent Event [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures				301,000
Stock Option Plan 1999 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options To Employees and Non Employees Outstanding Number (in shares)		436,093
Number of Shares, Granted		0
Stock Options To Employees and Non Employees Vested		2,031,409
Stock Option Plan 2010 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options To Employees and Non Employees Outstanding Number (in shares)		2,667,974
Stock Options Authorized To Be Issued To Employees and Non Employees		3,500,000
Criteria For Increase In Number Of Shares Reserved For Options		percent (4%) of the total outstanding shares on the last day of the prior calendar year, subject to a maximum annual increase of 250,000.
Stock Options To Employees and Non Employees Options Grants		3,807,423
Common Stock Shares Granted		66,081	146,555
Number of Shares, Granted		296,595
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights		The 2010 Plan options generally become exercisable over a four-year period (vesting 25% after one year, the remaining 75% vesting quarterly thereafter) and expire after ten years. During 2014, the majority of the employee incentive stock option grants vest on a schedule of 25% at the end of six months and 12.5% thereafter.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period		335,369
Common Stock, Capital Shares Reserved for Future Issuance		200,062
Stock Option Plan 2010 [Member] | Management Bonus [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Estimated Percentage On Management Bonus, Share Based Compensation		67.00%	67.00%
Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures		66,081
Allocated Share-based Compensation Expense		301,000	147,000
Stock Option Plan 2010 [Member] | Subsequent Event [Member] | Management Bonus [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Issued During Period, Value, Share-Based Compensation, Net Of Forfeitures		$117,577

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Federal tax benefit at statutory rate	($3,229)	($4,219)
State income tax, net of federal tax benefit	-119	-164
Effect of foreign operations	-4	-6
Research and experimentation credit	-19	-245
Stock based compensation	2,532	149
Derivative Liability	1,003	-539
Expiration of NOL	1,169	0
Permanent differences and other	-43	144
Change in valuation allowance	-1,290	4,880
Tax benefit	$0	$0

INCOME_TAXES_Details_1

INCOME TAXES (Details 1) (USD $)	Oct. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Deferred Tax Assets:
Inventory and other reserves	$709	$421
Net operating losses	47,823	47,581
Research and experimentation credits	5,198	5,209
Basis of property and equipment	237	194
Deferred stock compensation	561	2,758
Other	345	0
Long term deferred tax assets	54,164	55,742
Total deferred tax assets	54,873	56,163
Deferred Tax Liabilities:
Basis of property and equipment	0	0
Deferred tax liabilities	0	0
Valuation allowance	-54,873	-56,163
Net deferred tax asset	$0	$0

INCOME_TAXES_Details_Textual

INCOME TAXES (Details Textual) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	35.00%	35.00%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$1.30	$4.90
Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	5.2	5.2
Research Tax Credit Carryforward [Member] | Maximum [Member]
Tax Credit Carryforward, Expiration Date	31-Oct-33
Research Tax Credit Carryforward [Member] | Minimum [Member]
Tax Credit Carryforward, Expiration Date	31-Oct-18
Domestic Tax Authority [Member]
Operating Loss Carryforwards Expiration Dates1	2018 to 2033
Operating Loss Carryforwards	128.7	128
Foreign Tax Authority [Member]
Operating Loss Carryforwards	$3.90	$4

EMPLOYEE_BENEFITS_Details_Text

EMPLOYEE BENEFITS (Details Textual) (401(k) Savings Plan [Member], USD $)	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
401(k) Savings Plan [Member]
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Discretionary Contribution Amount	$184,000	$276,000
Defined Contribution Plan Vested Period	6 years

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details Textual) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2014
Related Party Transaction [Line Items]
Adjustments to Additional Paid in Capital, Warrant Issued	$1,374,000
2014 Private Placement Warrant [Member]
Related Party Transaction [Line Items]
Stock Issued During Period, Shares, Acquisitions		1,288,352
Adjustments to Additional Paid in Capital, Warrant Issued		2,900,000
Stock Issued During Period, Shares, New Issues		1,986,622
Shares Issued, Price Per Share		$2.26
Stock Issued During Period, Value, New Issues, Gross		4,500,000
Exercise Price Per Share Of Common Stock Issued By Conversion Of Warrants		$2.45
Iron Mountain Incorporated ("IRM") [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Proceeds from Terminated Contract		1,600,000
Revenue from Related Parties		550,000
Related party transaction, Gain Loss on Contract Termination		$1,050,000

PREFERRED_STOCK_RIGHTS_Details

PREFERRED STOCK RIGHTS (Details Textual) (USD $)	12 Months Ended
	Oct. 31, 2014	Oct. 31, 2013
Class of Stock [Line Items]
Preferred Stock, Participation Rights	one right for each outstanding share of common stock, par value $0.001 per share, and 5.0% Series F Convertible Preferred Stock, par value $0.001 per share, of the Company to stockholders of record as of the close of business on June 4, 2014.
Preferred Stock, Par Or Stated Value Per Share	$0.00	$0
Preferred Stock, Rights Entitlement	to purchase from the Company one one-thousandth of a share of Series G Participating Preferred Stock
Preferred Stock Rights Exercisable, Beneficial Ownership Percentage of Common Stock	4.99%
Series G Participating Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Par Or Stated Value Per Share	$0.00
Preferred Stock, Exercise Price Per One One-Thousandth	$14

SCHEDULE_II_VALUATION_AND_QUAL1

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) (Allowance for Doubtful Accounts [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Oct. 31, 2013
Allowance for Doubtful Accounts [Member]
Deducted from asset accounts:
Allowance for doubtful accounts, Balance at Beginning of Preiod	$94	$102
Allowance for doubtful accounts, Charged to Costs and Expenses	57	0
Allowance for doubtful accounts, Deductions	0	-8
Allowance for doubtful accounts, Balance at End of Period	$151	$94